Frequencies for first 10,000 rows of pt variable in reac2005q1 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 6 0.06 0.06 ABDOMINAL DISCOMFORT | 9 0.09 0.15 ABDOMINAL DISTENSION | 21 0.21 0.36 ABDOMINAL HAEMATOMA | 1 0.01 0.37 ABDOMINAL HERNIA | 1 0.01 0.38 ABDOMINAL INFECTION | 1 0.01 0.39 ABDOMINAL MASS | 1 0.01 0.40 ABDOMINAL OPERATION | 1 0.01 0.41 ABDOMINAL PAIN | 64 0.64 1.05 ABDOMINAL PAIN LOWER | 5 0.05 1.10 ABDOMINAL PAIN UPPER | 26 0.26 1.36 ABDOMINAL RIGIDITY | 1 0.01 1.37 ABDOMINAL TENDERNESS | 2 0.02 1.39 ABNORMAL BEHAVIOUR | 9 0.09 1.48 ABNORMAL DREAMS | 1 0.01 1.49 ABNORMAL FAECES | 2 0.02 1.51 ABNORMAL LABOUR | 1 0.01 1.52 ABNORMAL SENSATION IN EYE | 2 0.02 1.54 ABORTION INDUCED | 1 0.01 1.55 ABORTION SPONTANEOUS | 5 0.05 1.60 ABSCESS | 3 0.03 1.63 ABSCESS LIMB | 1 0.01 1.64 ACARODERMATITIS | 1 0.01 1.65 ACCELERATED HYPERTENSION | 1 0.01 1.66 ACCIDENT | 1 0.01 1.67 ACCIDENTAL DEATH | 1 0.01 1.68 ACCIDENTAL EXPOSURE | 3 0.03 1.71 ACCIDENTAL OVERDOSE | 6 0.06 1.77 ACIDOSIS | 4 0.04 1.81 ACNE | 10 0.10 1.91 ACOUSTIC STIMULATION TESTS ABNORMAL | 1 0.01 1.92 ACQUIRED CLAW TOE | 1 0.01 1.93 ACQUIRED DIAPHRAGMATIC EVENTRATION | 2 0.02 1.95 ACQUIRED DYSFIBRINOGENAEMIA | 1 0.01 1.96 ACTINIC KERATOSIS | 1 0.01 1.97 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 3 0.03 2.00 ACTIVITIES OF DAILY LIVING IMPAIRED | 4 0.04 2.04 ACUTE CORONARY SYNDROME | 2 0.02 2.06 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 1 0.01 2.07 ACUTE LEFT VENTRICULAR FAILURE | 1 0.01 2.08 ACUTE MYELOID LEUKAEMIA | 7 0.07 2.15 ACUTE MYOCARDIAL INFARCTION | 10 0.10 2.25 ACUTE PULMONARY OEDEMA | 4 0.04 2.29 ACUTE RESPIRATORY DISTRESS SYNDROME | 4 0.04 2.33 ACUTE RESPIRATORY FAILURE | 3 0.03 2.36 ACUTE RIGHT VENTRICULAR FAILURE | 1 0.01 2.37 ACUTE SINUSITIS | 2 0.02 2.39 ADHESION | 2 0.02 2.41 ADJUSTMENT DISORDER | 1 0.01 2.42 ADNEXA UTERI MASS | 1 0.01 2.43 ADNEXA UTERI PAIN | 1 0.01 2.44 ADRENAL INSUFFICIENCY | 2 0.02 2.46 ADVERSE DRUG REACTION | 2 0.02 2.48 ADVERSE EVENT | 20 0.20 2.68 AFFECT LABILITY | 4 0.04 2.72 AGEUSIA | 3 0.03 2.75 AGGRESSION | 23 0.23 2.98 AGITATION | 22 0.22 3.20 AGITATION NEONATAL | 1 0.01 3.21 AGRANULOCYTOSIS | 2 0.02 3.23 AIR EMBOLISM | 1 0.01 3.24 AKATHISIA | 2 0.02 3.26 AKINESIA | 1 0.01 3.27 ALANINE AMINOTRANSFERASE ABNORMAL | 1 0.01 3.28 ALANINE AMINOTRANSFERASE INCREASED | 39 0.39 3.67 ALCOHOL USE | 5 0.05 3.72 ALDOLASE INCREASED | 1 0.01 3.73 ALLERGIC GRANULOMATOUS ANGIITIS | 1 0.01 3.74 ALLERGY TO CHEMICALS | 1 0.01 3.75 ALOPECIA | 18 0.18 3.93 ALPHA 1 FOETOPROTEIN INCREASED | 1 0.01 3.94 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECT.. | 1 0.01 3.95 ALVEOLITIS ALLERGIC | 1 0.01 3.96 AMAUROSIS | 1 0.01 3.97 AMENORRHOEA | 11 0.11 4.08 AMMONIA INCREASED | 2 0.02 4.10 AMNESIA | 13 0.13 4.23 AMNESTIC DISORDER | 1 0.01 4.24 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 4.25 AMYOTROPHY | 1 0.01 4.26 ANAEMIA | 32 0.32 4.58 ANAEMIA MACROCYTIC | 2 0.02 4.60 ANAEMIA MEGALOBLASTIC | 2 0.02 4.62 ANAEMIA OF CHRONIC DISEASE | 1 0.01 4.63 ANAESTHETIC COMPLICATION | 5 0.05 4.68 ANAL CANCER | 1 0.01 4.69 ANAL FISTULA | 1 0.01 4.70 ANAPHYLACTIC REACTION | 8 0.08 4.78 ANAPHYLACTIC SHOCK | 7 0.07 4.85 ANAPHYLACTOID REACTION | 2 0.02 4.87 ANEURYSM | 3 0.03 4.90 ANGER | 7 0.07 4.97 ANGINA PECTORIS | 12 0.12 5.09 ANGINA UNSTABLE | 3 0.03 5.12 ANGIONEUROTIC OEDEMA | 4 0.04 5.16 ANGIOPATHY | 1 0.01 5.17 ANGIOPLASTY | 1 0.01 5.18 ANGLE CLOSURE GLAUCOMA | 2 0.02 5.20 ANION GAP ABNORMAL | 1 0.01 5.21 ANKLE FRACTURE | 1 0.01 5.22 ANKYLOSING SPONDYLITIS | 1 0.01 5.23 ANOREXIA | 26 0.26 5.49 ANORGASMIA | 2 0.02 5.51 ANOSMIA | 2 0.02 5.53 ANOXIA | 1 0.01 5.54 ANOXIC ENCEPHALOPATHY | 1 0.01 5.55 ANTI-PLATELET ANTIBODY POSITIVE | 1 0.01 5.56 ANTIBODY TEST POSITIVE | 1 0.01 5.57 ANTICONVULSANT DRUG LEVEL ABOVE THERA.. | 1 0.01 5.58 ANTICONVULSANT DRUG LEVEL BELOW THERA.. | 2 0.02 5.60 ANTICONVULSANT DRUG LEVEL DECREASED | 2 0.02 5.62 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY P.. | 1 0.01 5.63 ANTINUCLEAR ANTIBODY POSITIVE | 3 0.03 5.66 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE | 3 0.03 5.69 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 5.70 ANTITHROMBIN III DECREASED | 1 0.01 5.71 ANTITHROMBIN III INCREASED | 1 0.01 5.72 ANURIA | 4 0.04 5.76 ANXIETY | 50 0.50 6.26 AORTIC ATHEROSCLEROSIS | 2 0.02 6.28 AORTIC STENOSIS | 2 0.02 6.30 AORTIC VALVE DISEASE MIXED | 1 0.01 6.31 AORTIC VALVE INCOMPETENCE | 4 0.04 6.35 APATHY | 4 0.04 6.39 APGAR SCORE LOW | 1 0.01 6.40 APHAGIA | 1 0.01 6.41 APHASIA | 7 0.07 6.48 APHONIA | 1 0.01 6.49 APLASIA PURE RED CELL | 2 0.02 6.51 APNOEA | 4 0.04 6.55 APNOEIC ATTACK | 1 0.01 6.56 APPENDICECTOMY | 1 0.01 6.57 APPLICATION SITE BRUISING | 1 0.01 6.58 APPLICATION SITE DERMATITIS | 7 0.07 6.65 APPLICATION SITE DISCOLOURATION | 8 0.08 6.73 APPLICATION SITE ERYTHEMA | 2 0.02 6.75 APPLICATION SITE EXCORIATION | 1 0.01 6.76 APPLICATION SITE IRRITATION | 5 0.05 6.81 APPLICATION SITE PAIN | 1 0.01 6.82 APPLICATION SITE PRURITUS | 8 0.08 6.90 APPLICATION SITE REACTION | 47 0.47 7.37 APPLICATION SITE WARMTH | 2 0.02 7.39 APRAXIA | 1 0.01 7.40 AREFLEXIA | 2 0.02 7.42 ARM AMPUTATION | 1 0.01 7.43 ARRHYTHMIA | 12 0.12 7.55 ARRHYTHMIA SUPRAVENTRICULAR | 2 0.02 7.57 ARTERIAL HAEMORRHAGE | 1 0.01 7.58 ARTERIAL INJURY | 1 0.01 7.59 ARTERIAL STENOSIS | 1 0.01 7.60 ARTERIOSCLEROSIS | 2 0.02 7.62 ARTHRALGIA | 44 0.44 8.06 ARTHRITIS | 9 0.09 8.15 ARTHRITIS BACTERIAL | 1 0.01 8.16 ARTHRITIS INFECTIVE | 1 0.01 8.17 ARTHROPATHY | 6 0.06 8.23 ARTHROPOD BITE | 1 0.01 8.24 ARTICULAR DISC DISORDER | 1 0.01 8.25 ASBESTOSIS | 1 0.01 8.26 ASCITES | 11 0.11 8.37 ASEPTIC NECROSIS BONE | 2 0.02 8.39 ASPARTATE AMINOTRANSFERASE ABNORMAL | 1 0.01 8.40 ASPARTATE AMINOTRANSFERASE INCREASED | 38 0.38 8.78 ASPERGILLOMA | 1 0.01 8.79 ASPIRATION | 1 0.01 8.80 ASTERIXIS | 1 0.01 8.81 ASTHENIA | 61 0.61 9.42 ASTHMA | 11 0.11 9.53 ATELECTASIS | 1 0.01 9.54 ATHEROSCLEROSIS | 6 0.06 9.60 ATOPY | 1 0.01 9.61 ATRIAL BIGEMINY | 1 0.01 9.62 ATRIAL FIBRILLATION | 16 0.16 9.78 ATRIAL FLUTTER | 1 0.01 9.79 ATRIAL TACHYCARDIA | 1 0.01 9.80 ATRIOVENTRICULAR BLOCK | 3 0.03 9.83 ATRIOVENTRICULAR BLOCK COMPLETE | 1 0.01 9.84 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 4 0.04 9.88 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 9.89 ATROPHY | 2 0.02 9.91 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 1 0.01 9.92 ATYPICAL MYCOBACTERIAL INFECTION | 3 0.03 9.95 AUTOIMMUNE DISORDER | 4 0.04 9.99 AUTOIMMUNE HEPATITIS | 2 0.02 10.01 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 2 0.02 10.03 AXILLARY MASS | 1 0.01 10.04 AZOTAEMIA | 3 0.03 10.07 B-CELL LYMPHOMA STAGE IV | 1 0.01 10.08 BACILLUS INFECTION | 1 0.01 10.09 BACK DISORDER | 3 0.03 10.12 BACK INJURY | 3 0.03 10.15 BACK PAIN | 27 0.27 10.42 BACTERIA STOOL IDENTIFIED | 1 0.01 10.43 BACTERIA URINE | 1 0.01 10.44 BACTERIA URINE IDENTIFIED | 1 0.01 10.45 BACTERIAL INFECTION | 7 0.07 10.52 BALANCE DISORDER | 12 0.12 10.64 BALANITIS | 1 0.01 10.65 BARRETT'S OESOPHAGUS | 1 0.01 10.66 BARTHOLINITIS | 1 0.01 10.67 BASAL CELL CARCINOMA | 4 0.04 10.71 BASEDOW'S DISEASE | 2 0.02 10.73 BASILAR ARTERY THROMBOSIS | 1 0.01 10.74 BASOPHIL COUNT ABNORMAL | 1 0.01 10.75 BEDRIDDEN | 1 0.01 10.76 BENIGN GASTROINTESTINAL NEOPLASM | 1 0.01 10.77 BENIGN INTRACRANIAL HYPERTENSION | 2 0.02 10.79 BENIGN NEOPLASM OF BLADDER | 1 0.01 10.80 BENIGN NEOPLASM OF EYE | 1 0.01 10.81 BENIGN OVARIAN TUMOUR | 1 0.01 10.82 BENIGN PROSTATIC HYPERPLASIA | 5 0.05 10.87 BILE DUCT OBSTRUCTION | 1 0.01 10.88 BILIARY TRACT DISORDER | 1 0.01 10.89 BILIRUBIN CONJUGATED INCREASED | 3 0.03 10.92 BIOPSY BONE MARROW ABNORMAL | 1 0.01 10.93 BIPOLAR DISORDER | 1 0.01 10.94 BIPOLAR I DISORDER | 1 0.01 10.95 BLADDER CANCER | 1 0.01 10.96 BLADDER DISORDER | 3 0.03 10.99 BLADDER DIVERTICULUM | 1 0.01 11.00 BLADDER NECK SCLEROSIS | 1 0.01 11.01 BLADDER OBSTRUCTION | 1 0.01 11.02 BLADDER SPASM | 2 0.02 11.04 BLADDER STENOSIS | 1 0.01 11.05 BLEEDING TIME PROLONGED | 2 0.02 11.07 BLINDNESS | 5 0.05 11.12 BLINDNESS TRANSIENT | 1 0.01 11.13 BLINDNESS UNILATERAL | 4 0.04 11.17 BLISTER | 5 0.05 11.22 BLOOD ALBUMIN DECREASED | 4 0.04 11.26 BLOOD ALCOHOL INCREASED | 1 0.01 11.27 BLOOD ALKALINE PHOSPHATASE DECREASED | 1 0.01 11.28 BLOOD ALKALINE PHOSPHATASE INCREASED | 16 0.16 11.44 BLOOD AMYLASE INCREASED | 1 0.01 11.45 BLOOD BICARBONATE ABNORMAL | 1 0.01 11.46 BLOOD BILIRUBIN INCREASED | 16 0.16 11.62 BLOOD BLISTER | 1 0.01 11.63 BLOOD CALCIUM DECREASED | 2 0.02 11.65 BLOOD CALCIUM INCREASED | 1 0.01 11.66 BLOOD CARBON MONOXIDE ABNORMAL | 1 0.01 11.67 BLOOD CHLORIDE DECREASED | 3 0.03 11.70 BLOOD CHOLESTEROL DECREASED | 1 0.01 11.71 BLOOD CHOLESTEROL INCREASED | 18 0.18 11.89 BLOOD CHOLINESTERASE INCREASED | 2 0.02 11.91 BLOOD CREATINE INCREASED | 2 0.02 11.93 BLOOD CREATINE PHOSPHOKINASE INCREASED | 24 0.24 12.17 BLOOD CREATINE PHOSPHOKINASE MB INCRE.. | 2 0.02 12.19 BLOOD CREATININE DECREASED | 1 0.01 12.20 BLOOD CREATININE INCREASED | 23 0.23 12.43 BLOOD CULTURE POSITIVE | 2 0.02 12.45 BLOOD DISORDER | 1 0.01 12.46 BLOOD ELECTROLYTES ABNORMAL | 1 0.01 12.47 BLOOD FIBRINOGEN INCREASED | 1 0.01 12.48 BLOOD FOLLICLE STIMULATING HORMONE DE.. | 1 0.01 12.49 BLOOD GLUCOSE ABNORMAL | 2 0.02 12.51 BLOOD GLUCOSE DECREASED | 8 0.08 12.59 BLOOD GLUCOSE FLUCTUATION | 3 0.03 12.62 BLOOD GLUCOSE INCREASED | 20 0.20 12.82 BLOOD IMMUNOGLOBULIN A DECREASED | 1 0.01 12.83 BLOOD IMMUNOGLOBULIN A INCREASED | 2 0.02 12.85 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 12.86 BLOOD IMMUNOGLOBULIN G DECREASED | 1 0.01 12.87 BLOOD IMMUNOGLOBULIN G INCREASED | 4 0.04 12.91 BLOOD IMMUNOGLOBULIN M DECREASED | 1 0.01 12.92 BLOOD LACTATE DEHYDROGENASE INCREASED | 20 0.20 13.12 BLOOD LACTIC ACID INCREASED | 2 0.02 13.14 BLOOD LUTEINISING HORMONE DECREASED | 1 0.01 13.15 BLOOD MAGNESIUM DECREASED | 2 0.02 13.17 BLOOD MAGNESIUM INCREASED | 1 0.01 13.18 BLOOD OSMOLARITY DECREASED | 1 0.01 13.19 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 13.20 BLOOD PHOSPHORUS DECREASED | 1 0.01 13.21 BLOOD PHOSPHORUS INCREASED | 1 0.01 13.22 BLOOD POTASSIUM DECREASED | 5 0.05 13.27 BLOOD POTASSIUM INCREASED | 9 0.09 13.36 BLOOD PRESSURE ABNORMAL | 1 0.01 13.37 BLOOD PRESSURE DECREASED | 12 0.12 13.49 BLOOD PRESSURE DIASTOLIC DECREASED | 1 0.01 13.50 BLOOD PRESSURE DIASTOLIC INCREASED | 2 0.02 13.52 BLOOD PRESSURE FLUCTUATION | 5 0.05 13.57 BLOOD PRESSURE INADEQUATELY CONTROLLED | 2 0.02 13.59 BLOOD PRESSURE INCREASED | 38 0.38 13.97 BLOOD PRESSURE SYSTOLIC DECREASED | 1 0.01 13.98 BLOOD PRESSURE SYSTOLIC INCREASED | 6 0.06 14.04 BLOOD SODIUM DECREASED | 8 0.08 14.12 BLOOD SODIUM INCREASED | 1 0.01 14.13 BLOOD TEST ABNORMAL | 3 0.03 14.16 BLOOD TESTOSTERONE DECREASED | 1 0.01 14.17 BLOOD THYROID STIMULATING HORMONE INC.. | 2 0.02 14.19 BLOOD TRIGLYCERIDES INCREASED | 5 0.05 14.24 BLOOD UREA DECREASED | 1 0.01 14.25 BLOOD UREA INCREASED | 17 0.17 14.42 BLOOD URINE | 1 0.01 14.43 BLOOD URINE PRESENT | 2 0.02 14.45 BODY HEIGHT DECREASED | 1 0.01 14.46 BODY TEMPERATURE DECREASED | 3 0.03 14.49 BODY TEMPERATURE INCREASED | 5 0.05 14.54 BONE MARROW DEPRESSION | 10 0.10 14.64 BONE PAIN | 3 0.03 14.67 BONE TUBERCULOSIS | 1 0.01 14.68 BORRELIA INFECTION | 1 0.01 14.69 BOWEL SOUNDS ABNORMAL | 1 0.01 14.70 BRADYARRHYTHMIA | 1 0.01 14.71 BRADYCARDIA | 13 0.13 14.84 BRADYKINESIA | 1 0.01 14.85 BRADYPHRENIA | 1 0.01 14.86 BRAIN ABSCESS | 1 0.01 14.87 BRAIN DAMAGE | 1 0.01 14.88 BRAIN DEATH | 1 0.01 14.89 BRAIN HERNIATION | 1 0.01 14.90 BRAIN NEOPLASM | 1 0.01 14.91 BRAIN OEDEMA | 6 0.06 14.97 BRAIN STEM AUDITORY EVOKED RESPONSE | 2 0.02 14.99 BRAIN STEM HAEMORRHAGE | 1 0.01 15.00 BRAIN STEM ISCHAEMIA | 1 0.01 15.01 BREAST CANCER | 179 1.79 16.80 BREAST CANCER FEMALE | 40 0.40 17.20 BREAST CANCER IN SITU | 2 0.02 17.22 BREAST CANCER METASTATIC | 5 0.05 17.27 BREAST CYST | 2 0.02 17.29 BREAST DISCHARGE | 4 0.04 17.33 BREAST DISCOMFORT | 2 0.02 17.35 BREAST DISORDER | 6 0.06 17.41 BREAST ENGORGEMENT | 1 0.01 17.42 BREAST HAEMORRHAGE | 1 0.01 17.43 BREAST MASS | 2 0.02 17.45 BREAST MICROCALCIFICATION | 1 0.01 17.46 BREAST NEOPLASM | 5 0.05 17.51 BREAST OPERATION | 1 0.01 17.52 BREAST PAIN | 4 0.04 17.56 BREAST SWELLING | 2 0.02 17.58 BREAST TENDERNESS | 28 0.28 17.86 BREECH PRESENTATION | 1 0.01 17.87 BRONCHIAL HYPERACTIVITY | 1 0.01 17.88 BRONCHIECTASIS | 2 0.02 17.90 BRONCHIOLITIS | 1 0.01 17.91 BRONCHITIS | 9 0.09 18.00 BRONCHITIS ACUTE | 3 0.03 18.03 BRONCHITIS CHRONIC | 1 0.01 18.04 BRONCHOPNEUMONIA | 3 0.03 18.07 BRONCHOSPASM | 2 0.02 18.09 BRUNNER'S GLAND HYPERPLASIA | 1 0.01 18.10 BRUXISM | 1 0.01 18.11 BUNDLE BRANCH BLOCK | 1 0.01 18.12 BUNDLE BRANCH BLOCK LEFT | 2 0.02 18.14 BUNDLE BRANCH BLOCK RIGHT | 2 0.02 18.16 BURNING SENSATION | 9 0.09 18.25 BURSITIS | 4 0.04 18.29 BUTTOCK PAIN | 1 0.01 18.30 C-REACTIVE PROTEIN INCREASED | 12 0.12 18.42 CAESAREAN SECTION | 8 0.08 18.50 CALCINOSIS | 1 0.01 18.51 CALCULUS BLADDER | 1 0.01 18.52 CALCULUS URINARY | 3 0.03 18.55 CANDIDIASIS | 5 0.05 18.60 CARBUNCLE | 1 0.01 18.61 CARCINOMA EXCISION | 1 0.01 18.62 CARDIAC ANEURYSM | 2 0.02 18.64 CARDIAC ARREST | 22 0.22 18.86 CARDIAC DISORDER | 17 0.17 19.03 CARDIAC ENZYMES INCREASED | 1 0.01 19.04 CARDIAC FAILURE | 18 0.18 19.22 CARDIAC FAILURE ACUTE | 1 0.01 19.23 CARDIAC FAILURE CONGESTIVE | 20 0.20 19.43 CARDIAC FIBRILLATION | 1 0.01 19.44 CARDIAC MURMUR | 6 0.06 19.50 CARDIAC PACEMAKER INSERTION | 2 0.02 19.52 CARDIAC VALVE DISEASE | 3 0.03 19.55 CARDIO-RESPIRATORY ARREST | 5 0.05 19.60 CARDIOACTIVE DRUG LEVEL DECREASED | 1 0.01 19.61 CARDIOACTIVE DRUG LEVEL INCREASED | 1 0.01 19.62 CARDIOGENIC SHOCK | 2 0.02 19.64 CARDIOMEGALY | 8 0.08 19.72 CARDIOMYOPATHY | 2 0.02 19.74 CARDIOPULMONARY FAILURE | 1 0.01 19.75 CARDIOSPASM | 1 0.01 19.76 CARDIOTOXICITY | 1 0.01 19.77 CARDIOVASCULAR DISORDER | 6 0.06 19.83 CAROTID ARTERY ANEURYSM | 1 0.01 19.84 CAROTID ARTERY DISEASE | 1 0.01 19.85 CAROTID ARTERY OCCLUSION | 3 0.03 19.88 CAROTID ARTERY STENOSIS | 5 0.05 19.93 CAROTID BRUIT | 1 0.01 19.94 CARPAL TUNNEL SYNDROME | 4 0.04 19.98 CATARACT | 8 0.08 20.06 CATHETER RELATED COMPLICATION | 3 0.03 20.09 CATHETER RELATED INFECTION | 2 0.02 20.11 CATHETER SITE HAEMORRHAGE | 1 0.01 20.12 CAUSTIC INJURY | 2 0.02 20.14 CD4 LYMPHOCYTES DECREASED | 2 0.02 20.16 CD4 LYMPHOCYTES INCREASED | 2 0.02 20.18 CELLULITIS | 15 0.15 20.33 CENTRAL NERVOUS SYSTEM INFECTION | 1 0.01 20.34 CENTRAL VENOUS PRESSURE DECREASED | 1 0.01 20.35 CEREBELLAR INFARCTION | 1 0.01 20.36 CEREBELLAR SYNDROME | 2 0.02 20.38 CEREBRAL ARTERIOVENOUS MALFORMATION H.. | 1 0.01 20.39 CEREBRAL ARTERY OCCLUSION | 4 0.04 20.43 CEREBRAL ARTERY STENOSIS | 2 0.02 20.45 CEREBRAL ARTERY THROMBOSIS | 1 0.01 20.46 CEREBRAL ATHEROSCLEROSIS | 1 0.01 20.47 CEREBRAL ATROPHY | 2 0.02 20.49 CEREBRAL ATROPHY CONGENITAL | 2 0.02 20.51 CEREBRAL HAEMATOMA | 3 0.03 20.54 CEREBRAL HAEMORRHAGE | 11 0.11 20.65 CEREBRAL INFARCTION | 8 0.08 20.73 CEREBRAL ISCHAEMIA | 3 0.03 20.76 CEREBRAL PARENCHYMAL CALCIFICATION | 1 0.01 20.77 CEREBRAL THROMBOSIS | 2 0.02 20.79 CEREBRAL VENTRICLE DILATATION | 4 0.04 20.83 CEREBROVASCULAR ACCIDENT | 67 0.67 21.50 CEREBROVASCULAR DISORDER | 1 0.01 21.51 CERVICAL DYSPLASIA | 2 0.02 21.53 CERVICAL ROOT PAIN | 1 0.01 21.54 CERVICOBRACHIAL SYNDROME | 2 0.02 21.56 CERVIX CARCINOMA | 2 0.02 21.58 CERVIX CARCINOMA RECURRENT | 1 0.01 21.59 CERVIX CARCINOMA STAGE III | 1 0.01 21.60 CHEILITIS | 1 0.01 21.61 CHEST DISCOMFORT | 17 0.17 21.78 CHEST INJURY | 1 0.01 21.79 CHEST PAIN | 57 0.57 22.36 CHEST WALL PAIN | 2 0.02 22.38 CHEST X-RAY ABNORMAL | 5 0.05 22.43 CHILD ABUSE | 1 0.01 22.44 CHILLS | 17 0.17 22.61 CHLOASMA | 2 0.02 22.63 CHOKING | 2 0.02 22.65 CHOLANGITIS ACUTE | 2 0.02 22.67 CHOLECYSTITIS | 3 0.03 22.70 CHOLECYSTITIS ACUTE | 2 0.02 22.72 CHOLECYSTITIS CHRONIC | 1 0.01 22.73 CHOLELITHIASIS | 6 0.06 22.79 CHONDROCALCINOSIS PYROPHOSPHATE | 1 0.01 22.80 CHONDROMALACIA | 1 0.01 22.81 CHONDROPATHY | 1 0.01 22.82 CHOREA | 1 0.01 22.83 CHOROIDAL DETACHMENT | 1 0.01 22.84 CHROMATURIA | 5 0.05 22.89 CHRONIC FATIGUE SYNDROME | 1 0.01 22.90 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE E.. | 1 0.01 22.91 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 5 0.05 22.96 CILIARY BODY DISORDER | 1 0.01 22.97 CIRCULATORY COLLAPSE | 8 0.08 23.05 CLEFT LIP AND PALATE | 1 0.01 23.06 CLONUS | 2 0.02 23.08 CLOSTRIDIAL INFECTION | 3 0.03 23.11 CLOSTRIDIUM COLITIS | 7 0.07 23.18 COAGULATION TEST ABNORMAL | 1 0.01 23.19 COAGULOPATHY | 2 0.02 23.21 COLD SWEAT | 6 0.06 23.27 COLITIS | 1 0.01 23.28 COLITIS ISCHAEMIC | 4 0.04 23.32 COLITIS ULCERATIVE | 2 0.02 23.34 COLLAGEN DISORDER | 1 0.01 23.35 COLLAPSE OF LUNG | 1 0.01 23.36 COLON CANCER STAGE II | 1 0.01 23.37 COLONIC ATONY | 1 0.01 23.38 COLONIC POLYP | 2 0.02 23.40 COLONIC STENOSIS | 1 0.01 23.41 COLORECTAL CANCER METASTATIC | 1 0.01 23.42 COMA | 14 0.14 23.56 COMMINUTED FRACTURE | 1 0.01 23.57 COMMUNICATION DISORDER | 1 0.01 23.58 COMPLETED SUICIDE | 14 0.14 23.72 COMPLEX PARTIAL SEIZURES | 3 0.03 23.75 COMPLICATION OF DEVICE REMOVAL | 2 0.02 23.77 COMPLICATIONS OF TRANSPLANTED KIDNEY | 2 0.02 23.79 COMPRESSION FRACTURE | 1 0.01 23.80 COMPUTERISED TOMOGRAM ABNORMAL | 3 0.03 23.83 COMPUTERISED TOMOGRAM THORAX ABNORMAL | 1 0.01 23.84 CONDITION AGGRAVATED | 43 0.43 24.27 CONFUSIONAL STATE | 43 0.43 24.70 CONGENITAL ANOMALY | 4 0.04 24.74 CONGENITAL ANOMALY IN OFFSPRING | 1 0.01 24.75 CONGENITAL CYTOMEGALOVIRUS INFECTION | 2 0.02 24.77 CONGENITAL EYE DISORDER | 1 0.01 24.78 CONGENITAL HAND MALFORMATION | 1 0.01 24.79 CONGENITAL HYDRONEPHROSIS | 1 0.01 24.80 CONGENITAL HYPOTHYROIDISM | 1 0.01 24.81 CONGENITAL INFECTION | 1 0.01 24.82 CONGENITAL LACRIMAL PASSAGE ANOMALY | 1 0.01 24.83 CONGENITAL NEUROLOGICAL DISORDER | 2 0.02 24.85 CONGENITAL SALIVARY GLAND ANOMALY | 1 0.01 24.86 CONGESTIVE CARDIOMYOPATHY | 1 0.01 24.87 CONJUNCTIVITIS | 6 0.06 24.93 CONJUNCTIVITIS ALLERGIC | 2 0.02 24.95 CONNECTIVE TISSUE DISORDER | 1 0.01 24.96 CONSTIPATION | 23 0.23 25.19 CONTRAINDICATION TO MEDICAL TREATMENT | 1 0.01 25.20 CONTRAST MEDIA REACTION | 3 0.03 25.23 CONTUSION | 12 0.12 25.35 CONVULSION | 61 0.61 25.96 CONVULSION NEONATAL | 1 0.01 25.97 COOMBS TEST POSITIVE | 1 0.01 25.98 COORDINATION ABNORMAL | 10 0.10 26.08 COR PULMONALE | 1 0.01 26.09 CORNEAL DISORDER | 1 0.01 26.10 CORONARY ARTERY ATHEROSCLEROSIS | 6 0.06 26.16 CORONARY ARTERY DISEASE | 19 0.19 26.35 CORONARY ARTERY OCCLUSION | 7 0.07 26.42 CORONARY ARTERY RESTENOSIS | 2 0.02 26.44 CORONARY ARTERY STENOSIS | 8 0.08 26.52 CORONARY ARTERY SURGERY | 1 0.01 26.53 CORONARY ARTERY THROMBOSIS | 2 0.02 26.55 COSTOCHONDRITIS | 1 0.01 26.56 COUGH | 29 0.29 26.85 COXIELLA INFECTION | 1 0.01 26.86 CRANIAL NEUROPATHY | 1 0.01 26.87 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 26.88 CREATININE RENAL CLEARANCE INCREASED | 1 0.01 26.89 CREPITATIONS | 2 0.02 26.91 CROHN'S DISEASE | 5 0.05 26.96 CRYING | 11 0.11 27.07 CRYOGLOBULINS PRESENT | 1 0.01 27.08 CRYPTOCOCCOSIS | 2 0.02 27.10 CRYPTORCHISM | 1 0.01 27.11 CRYSTAL ARTHROPATHY | 1 0.01 27.12 CSF SHUNT REMOVAL | 1 0.01 27.13 CULTURE URINE POSITIVE | 1 0.01 27.14 CUTANEOUS VASCULITIS | 1 0.01 27.15 CYANOSIS | 8 0.08 27.23 CYST | 2 0.02 27.25 CYST ASPIRATION | 1 0.01 27.26 CYSTITIS | 3 0.03 27.29 CYSTITIS HAEMORRHAGIC | 1 0.01 27.30 CYSTITIS NONINFECTIVE | 1 0.01 27.31 CYTOLYTIC HEPATITIS | 3 0.03 27.34 CYTOMEGALOVIRUS ANTIBODY POSITIVE | 1 0.01 27.35 CYTOMEGALOVIRUS ANTIGEN POSITIVE | 1 0.01 27.36 CYTOMEGALOVIRUS INFECTION | 2 0.02 27.38 CYTOMEGALOVIRUS VIRAEMIA | 1 0.01 27.39 DEAFNESS | 3 0.03 27.42 DEAFNESS NEUROSENSORY | 4 0.04 27.46 DEAFNESS UNILATERAL | 1 0.01 27.47 DEATH | 27 0.27 27.74 DECREASED ACTIVITY | 1 0.01 27.75 DECREASED APPETITE | 11 0.11 27.86 DECUBITUS ULCER | 2 0.02 27.88 DEEP VEIN THROMBOSIS | 22 0.22 28.10 DEHYDRATION | 24 0.24 28.34 DELIRIUM | 11 0.11 28.45 DELUSION | 2 0.02 28.47 DEMENTIA | 3 0.03 28.50 DEMENTIA ALZHEIMER'S TYPE | 2 0.02 28.52 DEPENDENCE | 3 0.03 28.55 DEPRESSED LEVEL OF CONSCIOUSNESS | 31 0.31 28.86 DEPRESSED MOOD | 3 0.03 28.89 DEPRESSION | 58 0.58 29.47 DEPRESSION POSTOPERATIVE | 1 0.01 29.48 DEPRESSIVE SYMPTOM | 1 0.01 29.49 DERMATITIS | 1 0.01 29.50 DERMATITIS ACNEIFORM | 1 0.01 29.51 DERMATITIS ALLERGIC | 5 0.05 29.56 DERMATITIS ATOPIC | 1 0.01 29.57 DERMATITIS BULLOUS | 2 0.02 29.59 DERMATITIS CONTACT | 2 0.02 29.61 DERMATITIS EXFOLIATIVE | 4 0.04 29.65 DEVELOPMENTAL COORDINATION DISORDER | 1 0.01 29.66 DEVELOPMENTAL DELAY | 2 0.02 29.68 DEVICE FAILURE | 25 0.25 29.93 DIABETES MELLITUS | 6 0.06 29.99 DIABETES MELLITUS INADEQUATE CONTROL | 3 0.03 30.02 DIABETES MELLITUS INSULIN-DEPENDENT | 2 0.02 30.04 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 2 0.02 30.06 DIABETIC COMPLICATION | 1 0.01 30.07 DIABETIC KETOACIDOSIS | 1 0.01 30.08 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC .. | 1 0.01 30.09 DIABETIC NEUROPATHY | 4 0.04 30.13 DIABETIC RETINOPATHY | 3 0.03 30.16 DIALYSIS | 6 0.06 30.22 DIARRHOEA | 56 0.56 30.78 DIARRHOEA HAEMORRHAGIC | 1 0.01 30.79 DIASTOLIC DYSFUNCTION | 10 0.10 30.89 DIET REFUSAL | 1 0.01 30.90 DIFFICULTY IN WALKING | 13 0.13 31.03 DIFFUSE ALVEOLAR DAMAGE | 1 0.01 31.04 DIFFUSE LARGE B-CELL LYMPHOMA | 2 0.02 31.06 DILATATION VENTRICULAR | 3 0.03 31.09 DIPLOPIA | 8 0.08 31.17 DISABILITY | 3 0.03 31.20 DISCOMFORT | 2 0.02 31.22 DISEASE PROGRESSION | 9 0.09 31.31 DISEASE RECURRENCE | 4 0.04 31.35 DISINHIBITION | 1 0.01 31.36 DISLOCATION OF VERTEBRA | 1 0.01 31.37 DISORIENTATION | 12 0.12 31.49 DISSEMINATED INTRAVASCULAR COAGULATION | 5 0.05 31.54 DISSEMINATED TUBERCULOSIS | 3 0.03 31.57 DISSOCIATIVE DISORDER | 1 0.01 31.58 DISTRACTIBILITY | 1 0.01 31.59 DISTURBANCE IN ATTENTION | 9 0.09 31.68 DIVERTICULITIS | 1 0.01 31.69 DIVERTICULUM | 3 0.03 31.72 DIZZINESS | 84 0.84 32.56 DIZZINESS EXERTIONAL | 1 0.01 32.57 DIZZINESS POSTURAL | 2 0.02 32.59 DROOLING | 1 0.01 32.60 DROP ATTACKS | 1 0.01 32.61 DRUG ABUSER | 4 0.04 32.65 DRUG DEPENDENCE | 2 0.02 32.67 DRUG EFFECT DECREASED | 9 0.09 32.76 DRUG ERUPTION | 5 0.05 32.81 DRUG EXPOSURE DURING PREGNANCY | 80 0.80 33.61 DRUG EXPOSURE VIA BREAST MILK | 1 0.01 33.62 DRUG HYPERSENSITIVITY | 6 0.06 33.68 DRUG INEFFECTIVE | 48 0.48 34.16 DRUG INTERACTION | 47 0.47 34.63 DRUG INTERACTION POTENTIATION | 2 0.02 34.65 DRUG INTOLERANCE | 5 0.05 34.70 DRUG LEVEL ABOVE THERAPEUTIC | 1 0.01 34.71 DRUG LEVEL DECREASED | 3 0.03 34.74 DRUG LEVEL FLUCTUATING | 1 0.01 34.75 DRUG LEVEL INCREASED | 6 0.06 34.81 DRUG SCREEN POSITIVE | 2 0.02 34.83 DRUG SPECIFIC ANTIBODY PRESENT | 1 0.01 34.84 DRUG TOXICITY | 11 0.11 34.95 DRUG WITHDRAWAL SYNDROME | 16 0.16 35.11 DRY EYE | 1 0.01 35.12 DRY MOUTH | 12 0.12 35.24 DRY SKIN | 4 0.04 35.28 DRY THROAT | 2 0.02 35.30 DUODENAL STENOSIS | 1 0.01 35.31 DUODENAL ULCER | 2 0.02 35.33 DUODENAL ULCER HAEMORRHAGE | 1 0.01 35.34 DUODENAL ULCER PERFORATION | 2 0.02 35.36 DUODENITIS | 3 0.03 35.39 DUPUYTREN'S CONTRACTURE | 1 0.01 35.40 DYSAESTHESIA | 3 0.03 35.43 DYSARTHRIA | 16 0.16 35.59 DYSGEUSIA | 7 0.07 35.66 DYSKINESIA | 6 0.06 35.72 DYSLALIA | 1 0.01 35.73 DYSLIPIDAEMIA | 1 0.01 35.74 DYSMENORRHOEA | 10 0.10 35.84 DYSPAREUNIA | 4 0.04 35.88 DYSPEPSIA | 6 0.06 35.94 DYSPHAGIA | 20 0.20 36.14 DYSPHEMIA | 1 0.01 36.15 DYSPHONIA | 6 0.06 36.21 DYSPNOEA | 78 0.78 36.99 DYSPNOEA AT REST | 2 0.02 37.01 DYSPNOEA EXERTIONAL | 5 0.05 37.06 DYSPNOEA PAROXYSMAL NOCTURNAL | 1 0.01 37.07 DYSSTASIA | 4 0.04 37.11 DYSTHYMIC DISORDER | 1 0.01 37.12 DYSTONIA | 1 0.01 37.13 DYSURIA | 8 0.08 37.21 EAR DISORDER | 2 0.02 37.23 EAR INFECTION | 2 0.02 37.25 EATING DISORDER | 4 0.04 37.29 ECCHYMOSIS | 4 0.04 37.33 ECTOPIC PREGNANCY | 1 0.01 37.34 ECZEMA | 5 0.05 37.39 EDUCATIONAL PROBLEM | 1 0.01 37.40 EJACULATION DISORDER | 4 0.04 37.44 EJECTION FRACTION DECREASED | 3 0.03 37.47 ELECTROCARDIOGRAM ABNORMAL | 4 0.04 37.51 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL | 1 0.01 37.52 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 37.53 ELECTROCARDIOGRAM QT CORRECTED INTERV.. | 8 0.08 37.61 ELECTROCARDIOGRAM QT PROLONGED | 8 0.08 37.69 ELECTROCARDIOGRAM R ON T PHENOMENON | 1 0.01 37.70 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 5 0.05 37.75 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL | 1 0.01 37.76 ELECTROCARDIOGRAM T WAVE AMPLITUDE DE.. | 1 0.01 37.77 ELECTROCARDIOGRAM T WAVE INVERSION | 1 0.01 37.78 ELECTROENCEPHALOGRAM ABNORMAL | 5 0.05 37.83 ELECTROLYTE IMBALANCE | 2 0.02 37.85 ELECTROMECHANICAL DISSOCIATION | 1 0.01 37.86 EMBOLIC CEREBRAL INFARCTION | 1 0.01 37.87 EMBOLIC STROKE | 1 0.01 37.88 EMBOLISM | 1 0.01 37.89 EMOTIONAL DISORDER | 5 0.05 37.94 EMOTIONAL DISTRESS | 10 0.10 38.04 EMPHYSEMA | 2 0.02 38.06 EMPYEMA | 1 0.01 38.07 ENANTHEMA | 1 0.01 38.08 ENCEPHALITIS | 1 0.01 38.09 ENCEPHALOPATHY | 4 0.04 38.13 ENDOCARDITIS | 1 0.01 38.14 ENDOCRINE OPHTHALMOPATHY | 1 0.01 38.15 ENDOLYMPHATIC HYDROPS | 1 0.01 38.16 ENDOMETRIAL HYPERPLASIA | 1 0.01 38.17 ENDOMETRIOSIS | 2 0.02 38.19 ENDOTOXIC SHOCK | 1 0.01 38.20 ENTERITIS | 3 0.03 38.23 ENTEROCOCCAL INFECTION | 1 0.01 38.24 ENTEROCOLITIS | 3 0.03 38.27 ENTEROCOLITIS HAEMORRHAGIC | 2 0.02 38.29 ENURESIS | 1 0.01 38.30 EOSINOPHIL COUNT ABNORMAL | 1 0.01 38.31 EOSINOPHIL COUNT INCREASED | 5 0.05 38.36 EOSINOPHILIA | 6 0.06 38.42 EPIDIDYMAL CYST | 1 0.01 38.43 EPIGLOTTITIS | 1 0.01 38.44 EPILEPSY | 6 0.06 38.50 EPILEPSY CONGENITAL | 2 0.02 38.52 EPISTAXIS | 3 0.03 38.55 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 38.57 ERECTILE DYSFUNCTION | 28 0.28 38.85 ERECTION INCREASED | 3 0.03 38.88 ERUCTATION | 2 0.02 38.90 ERYSIPELAS | 1 0.01 38.91 ERYTHEMA | 17 0.17 39.08 ERYTHEMA INDURATUM | 2 0.02 39.10 ERYTHEMA MULTIFORME | 5 0.05 39.15 ERYTHEMA NODOSUM | 2 0.02 39.17 ERYTHROPENIA | 1 0.01 39.18 ESCHERICHIA BACTERAEMIA | 1 0.01 39.19 ESCHERICHIA INFECTION | 4 0.04 39.23 EUPHORIC MOOD | 4 0.04 39.27 EUTHYROID SICK SYNDROME | 1 0.01 39.28 EVAN'S SYNDROME | 1 0.01 39.29 EXERCISE ELECTROCARDIOGRAM ABNORMAL | 1 0.01 39.30 EXOSTOSIS | 2 0.02 39.32 EXTRAPYRAMIDAL DISORDER | 1 0.01 39.33 EXTRASYSTOLES | 3 0.03 39.36 EYE DISORDER | 1 0.01 39.37 EYE HAEMORRHAGE | 5 0.05 39.42 EYE INFECTION | 1 0.01 39.43 EYE INFLAMMATION | 1 0.01 39.44 EYE INJURY | 1 0.01 39.45 EYE IRRITATION | 2 0.02 39.47 EYE MOVEMENT DISORDER | 5 0.05 39.52 EYE PAIN | 4 0.04 39.56 EYE PRURITUS | 3 0.03 39.59 EYE ROLLING | 2 0.02 39.61 EYE SWELLING | 4 0.04 39.65 EYELASH DISCOLOURATION | 1 0.01 39.66 EYELID OEDEMA | 1 0.01 39.67 EYELID PTOSIS | 1 0.01 39.68 FACE OEDEMA | 6 0.06 39.74 FACIAL BONES FRACTURE | 2 0.02 39.76 FACIAL DYSMORPHISM | 1 0.01 39.77 FACIAL PAIN | 2 0.02 39.79 FACIAL PALSY | 8 0.08 39.87 FACIAL PARESIS | 3 0.03 39.90 FACTOR V INHIBITION | 2 0.02 39.92 FACTOR V LEIDEN MUTATION | 1 0.01 39.93 FAECAL INCONTINENCE | 5 0.05 39.98 FAECES DISCOLOURED | 6 0.06 40.04 FAILURE TO ANASTOMOSE | 1 0.01 40.05 FALL | 40 0.40 40.45 FAT TISSUE INCREASED | 1 0.01 40.46 FATIGUE | 67 0.67 41.13 FEAR | 2 0.02 41.15 FEAR OF DISEASE | 1 0.01 41.16 FEBRILE BONE MARROW APLASIA | 1 0.01 41.17 FEBRILE INFECTION | 1 0.01 41.18 FEBRILE NEUTROPENIA | 7 0.07 41.25 FEEDING DISORDER | 2 0.02 41.27 FEEDING PROBLEM IN NEWBORN | 1 0.01 41.28 FEELING ABNORMAL | 41 0.41 41.69 FEELING COLD | 4 0.04 41.73 FEELING DRUNK | 2 0.02 41.75 FEELING HOT | 7 0.07 41.82 FEELING JITTERY | 4 0.04 41.86 FEELING OF DESPAIR | 1 0.01 41.87 FEMORAL ARTERY OCCLUSION | 1 0.01 41.88 FEMORAL NECK FRACTURE | 3 0.03 41.91 FEMUR FRACTURE | 1 0.01 41.92 FIBRIN D DIMER INCREASED | 1 0.01 41.93 FIBRIN DEGRADATION PRODUCTS INCREASED | 1 0.01 41.94 FIBROMYALGIA | 4 0.04 41.98 FISTULA | 1 0.01 41.99 FLANK PAIN | 1 0.01 42.00 FLAT FEET | 1 0.01 42.01 FLATULENCE | 9 0.09 42.10 FLIGHT OF IDEAS | 2 0.02 42.12 FLUID INTAKE REDUCED | 1 0.01 42.13 FLUID RETENTION | 6 0.06 42.19 FLUOROSIS | 1 0.01 42.20 FLUSHING | 10 0.10 42.30 FOCAL NODULAR HYPERPLASIA | 1 0.01 42.31 FOETAL ARRHYTHMIA | 1 0.01 42.32 FOETAL DISTRESS SYNDROME | 1 0.01 42.33 FOLATE DEFICIENCY | 1 0.01 42.34 FOLLICULITIS | 1 0.01 42.35 FONTANELLE BULGING | 2 0.02 42.37 FOOD ALLERGY | 1 0.01 42.38 FOOD INTERACTION | 2 0.02 42.40 FOOD INTOLERANCE | 1 0.01 42.41 FOOD POISONING | 2 0.02 42.43 FOOT FRACTURE | 3 0.03 42.46 FOREIGN BODY ASPIRATION | 1 0.01 42.47 FOREIGN BODY TRAUMA | 2 0.02 42.49 FORMICATION | 1 0.01 42.50 FRACTURE | 2 0.02 42.52 FRACTURE MALUNION | 1 0.01 42.53 FREQUENT BOWEL MOVEMENTS | 2 0.02 42.55 FULL BLOOD COUNT ABNORMAL | 1 0.01 42.56 FUNDOPLICATION | 1 0.01 42.57 FUNGAEMIA | 2 0.02 42.59 FUNGAL INFECTION | 8 0.08 42.67 FUNGAL PERITONITIS | 1 0.01 42.68 FUNGAL SKIN INFECTION | 1 0.01 42.69 GAIT DISTURBANCE | 10 0.10 42.79 GALACTORRHOEA | 3 0.03 42.82 GALLBLADDER DISORDER | 1 0.01 42.83 GALLBLADDER PERFORATION | 1 0.01 42.84 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 18 0.18 43.02 GASTRECTOMY | 1 0.01 43.03 GASTRIC CANCER | 2 0.02 43.05 GASTRIC DISORDER | 4 0.04 43.09 GASTRIC HAEMORRHAGE | 2 0.02 43.11 GASTRIC PH INCREASED | 1 0.01 43.12 GASTRIC ULCER | 4 0.04 43.16 GASTRIC ULCER HAEMORRHAGE | 1 0.01 43.17 GASTRITIS | 14 0.14 43.31 GASTRITIS HAEMORRHAGIC | 1 0.01 43.32 GASTROENTERITIS | 7 0.07 43.39 GASTROENTERITIS RADIATION | 1 0.01 43.40 GASTROENTERITIS VIRAL | 2 0.02 43.42 GASTROINTESTINAL DISORDER | 7 0.07 43.49 GASTROINTESTINAL DYSPLASIA | 1 0.01 43.50 GASTROINTESTINAL HAEMORRHAGE | 12 0.12 43.62 GASTROINTESTINAL INJURY | 1 0.01 43.63 GASTROINTESTINAL MUCOSAL NECROSIS | 1 0.01 43.64 GASTROINTESTINAL NECROSIS | 1 0.01 43.65 GASTROINTESTINAL OBSTRUCTION | 1 0.01 43.66 GASTROINTESTINAL PAIN | 3 0.03 43.69 GASTROINTESTINAL PERFORATION | 3 0.03 43.72 GASTROOESOPHAGEAL REFLUX DISEASE | 12 0.12 43.84 GAZE PALSY | 2 0.02 43.86 GENERAL PHYSICAL HEALTH DETERIORATION | 18 0.18 44.04 GENERAL SYMPTOM | 4 0.04 44.08 GENERALISED ANXIETY DISORDER | 2 0.02 44.10 GENERALISED ERYTHEMA | 1 0.01 44.11 GENERALISED OEDEMA | 3 0.03 44.14 GENITAL BURNING SENSATION | 2 0.02 44.16 GENITAL CANDIDIASIS | 1 0.01 44.17 GENITAL HAEMORRHAGE | 1 0.01 44.18 GENITAL PRURITUS FEMALE | 4 0.04 44.22 GENITAL PRURITUS MALE | 1 0.01 44.23 GENITAL ULCERATION | 1 0.01 44.24 GILBERT'S SYNDROME | 1 0.01 44.25 GINGIVAL BLEEDING | 1 0.01 44.26 GINGIVAL ULCERATION | 1 0.01 44.27 GLASGOW COMA SCALE ABNORMAL | 1 0.01 44.28 GLAUCOMA | 7 0.07 44.35 GLIOBLASTOMA MULTIFORME | 1 0.01 44.36 GLOMERULONEPHRITIS | 2 0.02 44.38 GLOMERULONEPHRITIS MEMBRANOUS | 1 0.01 44.39 GLOMERULOSCLEROSIS | 1 0.01 44.40 GLUCOSE TOLERANCE IMPAIRED | 3 0.03 44.43 GLYCOSURIA | 2 0.02 44.45 GLYCOSYLATED HAEMOGLOBIN INCREASED | 1 0.01 44.46 GOUT | 6 0.06 44.52 GOUTY ARTHRITIS | 1 0.01 44.53 GRAFT VERSUS HOST DISEASE | 3 0.03 44.56 GRAND MAL CONVULSION | 14 0.14 44.70 GRANULOCYTOPENIA | 1 0.01 44.71 GRANULOMA ANNULARE | 1 0.01 44.72 GRIP STRENGTH DECREASED | 1 0.01 44.73 GROIN PAIN | 2 0.02 44.75 GUILLAIN-BARRE SYNDROME | 1 0.01 44.76 GUM NEOPLASM MALIGNANT STAGE UNSPECIF.. | 1 0.01 44.77 GUN SHOT WOUND | 2 0.02 44.79 GYNAECOMASTIA | 1 0.01 44.80 HAEMANGIOMA | 1 0.01 44.81 HAEMARTHROSIS | 2 0.02 44.83 HAEMATEMESIS | 5 0.05 44.88 HAEMATOCHEZIA | 7 0.07 44.95 HAEMATOCRIT DECREASED | 8 0.08 45.03 HAEMATOMA | 5 0.05 45.08 HAEMATURIA | 6 0.06 45.14 HAEMOCHROMATOSIS | 1 0.01 45.15 HAEMODIALYSIS | 11 0.11 45.26 HAEMODYNAMIC INSTABILITY | 2 0.02 45.28 HAEMOGLOBIN ABNORMAL | 2 0.02 45.30 HAEMOGLOBIN DECREASED | 24 0.24 45.54 HAEMOGLOBIN INCREASED | 1 0.01 45.55 HAEMOLYSIS | 4 0.04 45.59 HAEMOLYTIC ANAEMIA | 3 0.03 45.62 HAEMOLYTIC URAEMIC SYNDROME | 3 0.03 45.65 HAEMOPHILUS INFECTION | 1 0.01 45.66 HAEMOPTYSIS | 7 0.07 45.73 HAEMORRHAGE | 25 0.25 45.98 HAEMORRHAGE INTRACRANIAL | 2 0.02 46.00 HAEMORRHAGE URINARY TRACT | 3 0.03 46.03 HAEMORRHAGIC DIATHESIS | 3 0.03 46.06 HAEMORRHAGIC OVARIAN CYST | 1 0.01 46.07 HAEMORRHAGIC STROKE | 1 0.01 46.08 HAEMORRHOIDAL HAEMORRHAGE | 3 0.03 46.11 HAEMORRHOIDS | 4 0.04 46.15 HAEMOTHORAX | 1 0.01 46.16 HAIR TEXTURE ABNORMAL | 1 0.01 46.17 HALITOSIS | 1 0.01 46.18 HALLUCINATION | 17 0.17 46.35 HALLUCINATION, AUDITORY | 5 0.05 46.40 HALLUCINATION, TACTILE | 1 0.01 46.41 HALLUCINATION, VISUAL | 5 0.05 46.46 HALLUCINATIONS, MIXED | 1 0.01 46.47 HEAD INJURY | 6 0.06 46.53 HEADACHE | 130 1.30 47.83 HEARING IMPAIRED | 2 0.02 47.85 HEART INJURY | 1 0.01 47.86 HEART RATE DECREASED | 5 0.05 47.91 HEART RATE INCREASED | 17 0.17 48.08 HEART RATE IRREGULAR | 7 0.07 48.15 HEAT EXHAUSTION | 1 0.01 48.16 HELICOBACTER GASTRITIS | 1 0.01 48.17 HELICOBACTER INFECTION | 2 0.02 48.19 HELICOBACTER PYLORI IDENTIFICATION TE.. | 1 0.01 48.20 HEMIANOPIA | 1 0.01 48.21 HEMIANOPIA HOMONYMOUS | 1 0.01 48.22 HEMIPARESIS | 8 0.08 48.30 HEMIPLEGIA | 1 0.01 48.31 HEMIVERTEBRA | 1 0.01 48.32 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 48.33 HEPATIC ADENOMA | 1 0.01 48.34 HEPATIC CIRRHOSIS | 3 0.03 48.37 HEPATIC ENCEPHALOPATHY | 2 0.02 48.39 HEPATIC ENZYME INCREASED | 8 0.08 48.47 HEPATIC FAILURE | 11 0.11 48.58 HEPATIC FUNCTION ABNORMAL | 16 0.16 48.74 HEPATIC INFECTION | 1 0.01 48.75 HEPATIC NECROSIS | 2 0.02 48.77 HEPATIC NEOPLASM | 1 0.01 48.78 HEPATIC NEOPLASM MALIGNANT | 2 0.02 48.80 HEPATIC RUPTURE | 1 0.01 48.81 HEPATIC STEATOSIS | 3 0.03 48.84 HEPATIC VEIN OCCLUSION | 1 0.01 48.85 HEPATITIS | 16 0.16 49.01 HEPATITIS A | 1 0.01 49.02 HEPATITIS B | 1 0.01 49.03 HEPATITIS B VIRUS | 1 0.01 49.04 HEPATITIS C VIRUS | 1 0.01 49.05 HEPATITIS CHOLESTATIC | 2 0.02 49.07 HEPATITIS FULMINANT | 2 0.02 49.09 HEPATOCELLULAR DAMAGE | 3 0.03 49.12 HEPATOMEGALY | 5 0.05 49.17 HEPATORENAL SYNDROME | 1 0.01 49.18 HEPATOSPLENOMEGALY | 3 0.03 49.21 HEPATOTOXICITY | 4 0.04 49.25 HERNIA | 4 0.04 49.29 HERPES SIMPLEX | 4 0.04 49.33 HERPES ZOSTER | 8 0.08 49.41 HIATUS HERNIA | 5 0.05 49.46 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 49.47 HIGH DENSITY LIPOPROTEIN INCREASED | 1 0.01 49.48 HIP FRACTURE | 7 0.07 49.55 HIRSUTISM | 1 0.01 49.56 HISTIOCYTOSIS HAEMATOPHAGIC | 2 0.02 49.58 HISTOPLASMOSIS | 3 0.03 49.61 HIV INFECTION | 2 0.02 49.63 HOMICIDAL IDEATION | 3 0.03 49.66 HOSPITALISATION | 2 0.02 49.68 HOSTILITY | 1 0.01 49.69 HOT FLUSH | 11 0.11 49.80 HYDROCEPHALUS | 2 0.02 49.82 HYDRONEPHROSIS | 3 0.03 49.85 HYPERACUSIS | 1 0.01 49.86 HYPERAESTHESIA | 3 0.03 49.89 HYPERBILIRUBINAEMIA | 1 0.01 49.90 HYPERCALCAEMIA | 1 0.01 49.91 HYPERCAPNIA | 2 0.02 49.93 HYPERCHOLESTEROLAEMIA | 3 0.03 49.96 HYPERCOAGULATION | 2 0.02 49.98 HYPERGAMMAGLOBULINAEMIA | 1 0.01 49.99 HYPERGLYCAEMIA | 6 0.06 50.05 HYPERHIDROSIS | 26 0.26 50.31 HYPERKALAEMIA | 8 0.08 50.39 HYPERLIPIDAEMIA | 11 0.11 50.50 HYPEROSMOLAR STATE | 1 0.01 50.51 HYPERPHOSPHATAEMIA | 4 0.04 50.55 HYPERPLASIA | 1 0.01 50.56 HYPERPROLACTINAEMIA | 2 0.02 50.58 HYPERPYREXIA | 1 0.01 50.59 HYPERREFLEXIA | 3 0.03 50.62 HYPERSENSITIVITY | 16 0.16 50.78 HYPERSOMNIA | 5 0.05 50.83 HYPERTELORISM OF ORBIT | 1 0.01 50.84 HYPERTENSION | 39 0.39 51.23 HYPERTENSIVE CRISIS | 3 0.03 51.26 HYPERTENSIVE HEART DISEASE | 2 0.02 51.28 HYPERTENSIVE NEPHROPATHY | 1 0.01 51.29 HYPERTHERMIA | 2 0.02 51.31 HYPERTHERMIA MALIGNANT | 2 0.02 51.33 HYPERTHYROIDISM | 2 0.02 51.35 HYPERTONIA | 2 0.02 51.37 HYPERTRIGLYCERIDAEMIA | 2 0.02 51.39 HYPERTROPHY BREAST | 15 0.15 51.54 HYPERURICAEMIA | 2 0.02 51.56 HYPERVENTILATION | 4 0.04 51.60 HYPERVISCOSITY SYNDROME | 1 0.01 51.61 HYPOACUSIS | 2 0.02 51.63 HYPOAESTHESIA | 32 0.32 51.95 HYPOAESTHESIA ORAL | 2 0.02 51.97 HYPOALBUMINAEMIA | 2 0.02 51.99 HYPOCALCAEMIA | 3 0.03 52.02 HYPOCOAGULABLE STATE | 1 0.01 52.03 HYPOGLYCAEMIA | 22 0.22 52.25 HYPOGLYCAEMIA NEONATAL | 2 0.02 52.27 HYPOKALAEMIA | 7 0.07 52.34 HYPOKINESIA | 4 0.04 52.38 HYPOMAGNESAEMIA | 1 0.01 52.39 HYPOMENORRHOEA | 5 0.05 52.44 HYPONATRAEMIA | 16 0.16 52.60 HYPOPHOSPHATAEMIA | 1 0.01 52.61 HYPOPROTEINAEMIA | 2 0.02 52.63 HYPOREFLEXIA | 4 0.04 52.67 HYPOSPADIAS | 1 0.01 52.68 HYPOTENSION | 37 0.37 53.05 HYPOTHERMIA | 2 0.02 53.07 HYPOTHYROIDISM | 5 0.05 53.12 HYPOTONIA | 6 0.06 53.18 HYPOTONIA NEONATAL | 2 0.02 53.20 HYPOTRICHOSIS | 4 0.04 53.24 HYPOVENTILATION | 3 0.03 53.27 HYPOVOLAEMIA | 3 0.03 53.30 HYPOXIA | 15 0.15 53.45 HYSTERECTOMY | 1 0.01 53.46 IATROGENIC INJURY | 2 0.02 53.48 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 53.49 IIIRD NERVE PARALYSIS | 1 0.01 53.50 ILEAL ULCER | 1 0.01 53.51 ILEOSTOMY CLOSURE | 1 0.01 53.52 ILEUS | 4 0.04 53.56 ILEUS PARALYTIC | 3 0.03 53.59 ILL-DEFINED DISORDER | 3 0.03 53.62 IMMUNE RECONSTITUTION SYNDROME | 1 0.01 53.63 IMMUNE SYSTEM DISORDER | 1 0.01 53.64 IMMUNOGLOBULINS DECREASED | 1 0.01 53.65 IMMUNOSUPPRESSION | 3 0.03 53.68 IMPAIRED DRIVING ABILITY | 1 0.01 53.69 IMPAIRED GASTRIC EMPTYING | 2 0.02 53.71 IMPAIRED WORK ABILITY | 6 0.06 53.77 IMPULSE-CONTROL DISORDER | 1 0.01 53.78 IMPULSIVE BEHAVIOUR | 1 0.01 53.79 INABILITY TO CRAWL | 1 0.01 53.80 INADEQUATE ANALGESIA | 1 0.01 53.81 INAPPROPRIATE AFFECT | 1 0.01 53.82 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 5 0.05 53.87 INCOHERENT | 1 0.01 53.88 INCONTINENCE | 6 0.06 53.94 INCORRECT DOSE ADMINISTERED | 1 0.01 53.95 INCREASED APPETITE | 4 0.04 53.99 INCREASED TENDENCY TO BRUISE | 1 0.01 54.00 INDUCED LABOUR | 3 0.03 54.03 INFECTION | 14 0.14 54.17 INFECTIOUS MONONUCLEOSIS | 1 0.01 54.18 INFLAMMATION | 11 0.11 54.29 INFLAMMATORY BOWEL DISEASE | 3 0.03 54.32 INFLUENZA | 2 0.02 54.34 INFLUENZA LIKE ILLNESS | 6 0.06 54.40 INFUSION RELATED REACTION | 14 0.14 54.54 INFUSION SITE INFECTION | 1 0.01 54.55 INFUSION SITE PAIN | 1 0.01 54.56 INFUSION SITE REACTION | 1 0.01 54.57 INGUINAL HERNIA | 1 0.01 54.58 INITIAL INSOMNIA | 2 0.02 54.60 INJECTION SITE ABSCESS | 1 0.01 54.61 INJECTION SITE ABSCESS STERILE | 1 0.01 54.62 INJECTION SITE DERMATITIS | 1 0.01 54.63 INJECTION SITE DISCOLOURATION | 1 0.01 54.64 INJECTION SITE HAEMORRHAGE | 5 0.05 54.69 INJECTION SITE INDURATION | 1 0.01 54.70 INJECTION SITE IRRITATION | 3 0.03 54.73 INJECTION SITE NODULE | 1 0.01 54.74 INJECTION SITE PAIN | 3 0.03 54.77 INJECTION SITE PRURITUS | 1 0.01 54.78 INJECTION SITE REACTION | 2 0.02 54.80 INJECTION SITE URTICARIA | 2 0.02 54.82 INJURY | 16 0.16 54.98 INJURY ASPHYXIATION | 2 0.02 55.00 INSOMNIA | 43 0.43 55.43 INTENTION TREMOR | 1 0.01 55.44 INTENTIONAL MISUSE | 27 0.27 55.71 INTENTIONAL SELF-INJURY | 1 0.01 55.72 INTERCOSTAL NEURALGIA | 1 0.01 55.73 INTERMITTENT CLAUDICATION | 1 0.01 55.74 INTERNATIONAL NORMALISED RATIO ABNORMAL | 1 0.01 55.75 INTERNATIONAL NORMALISED RATIO DECREA.. | 1 0.01 55.76 INTERNATIONAL NORMALISED RATIO FLUCTU.. | 1 0.01 55.77 INTERNATIONAL NORMALISED RATIO INCREA.. | 11 0.11 55.88 INTERSTITIAL LUNG DISEASE | 16 0.16 56.04 INTERVERTEBRAL DISC DEGENERATION | 2 0.02 56.06 INTERVERTEBRAL DISC DISORDER | 1 0.01 56.07 INTERVERTEBRAL DISC PROTRUSION | 4 0.04 56.11 INTERVERTEBRAL DISC SPACE NARROWING | 1 0.01 56.12 INTESTINAL DILATATION | 2 0.02 56.14 INTESTINAL FISTULA | 1 0.01 56.15 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 56.16 INTESTINAL HYPOMOTILITY | 1 0.01 56.17 INTESTINAL INFARCTION | 1 0.01 56.18 INTESTINAL ISCHAEMIA | 1 0.01 56.19 INTESTINAL OBSTRUCTION | 4 0.04 56.23 INTESTINAL PERFORATION | 1 0.01 56.24 INTESTINAL POLYP | 1 0.01 56.25 INTESTINAL SPASM | 1 0.01 56.26 INTRA-UTERINE DEATH | 1 0.01 56.27 INTRACARDIAC THROMBUS | 3 0.03 56.30 INTRAVENTRICULAR HAEMORRHAGE | 1 0.01 56.31 INTRAVENTRICULAR HAEMORRHAGE NEONATAL | 2 0.02 56.33 IRON DEFICIENCY | 1 0.01 56.34 IRON DEFICIENCY ANAEMIA | 1 0.01 56.35 IRREGULAR SLEEP PHASE | 1 0.01 56.36 IRRITABILITY | 16 0.16 56.52 IRRITABLE BOWEL SYNDROME | 5 0.05 56.57 ISCHAEMIA | 1 0.01 56.58 ISCHAEMIC CARDIOMYOPATHY | 2 0.02 56.60 ISCHAEMIC HEPATITIS | 2 0.02 56.62 ISCHAEMIC STROKE | 4 0.04 56.66 JAUNDICE | 7 0.07 56.73 JAUNDICE CHOLESTATIC | 1 0.01 56.74 JAUNDICE NEONATAL | 3 0.03 56.77 JAW DISORDER | 1 0.01 56.78 JOINT CONTRACTURE | 1 0.01 56.79 JOINT CREPITATION | 1 0.01 56.80 JOINT DISLOCATION | 2 0.02 56.82 JOINT EFFUSION | 1 0.01 56.83 JOINT INJURY | 2 0.02 56.85 JOINT RANGE OF MOTION DECREASED | 2 0.02 56.87 JOINT SPRAIN | 2 0.02 56.89 JOINT STIFFNESS | 1 0.01 56.90 JOINT SWELLING | 10 0.10 57.00 JOINT WARMTH | 1 0.01 57.01 KERATOCONJUNCTIVITIS SICCA | 1 0.01 57.02 KETOACIDOSIS | 2 0.02 57.04 KIDNEY INFECTION | 1 0.01 57.05 KIDNEY MALFORMATION | 1 0.01 57.06 KIDNEY TRANSPLANT REJECTION | 4 0.04 57.10 KLEBSIELLA INFECTION | 4 0.04 57.14 KNEE ARTHROPLASTY | 2 0.02 57.16 KUSSMAUL RESPIRATION | 1 0.01 57.17 KYPHOSIS | 1 0.01 57.18 LABORATORY TEST ABNORMAL | 5 0.05 57.23 LACERATION | 1 0.01 57.24 LACTIC ACIDOSIS | 4 0.04 57.28 LACTOSE INTOLERANCE | 2 0.02 57.30 LACUNAR INFARCTION | 6 0.06 57.36 LARGE INTESTINAL ULCER | 3 0.03 57.39 LARGE INTESTINE PERFORATION | 1 0.01 57.40 LARYNGEAL OEDEMA | 1 0.01 57.41 LEARNING DISORDER | 1 0.01 57.42 LEFT VENTRICULAR FAILURE | 2 0.02 57.44 LEG AMPUTATION | 1 0.01 57.45 LETHARGY | 16 0.16 57.61 LEUKAEMIA | 1 0.01 57.62 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 57.63 LEUKOCYTOSIS | 5 0.05 57.68 LEUKOPENIA | 10 0.10 57.78 LIBIDO DECREASED | 4 0.04 57.82 LIBIDO INCREASED | 2 0.02 57.84 LICHEN PLANUS | 2 0.02 57.86 LIGAMENT DISORDER | 1 0.01 57.87 LIMB DISCOMFORT | 1 0.01 57.88 LIMB INJURY | 3 0.03 57.91 LIMB OPERATION | 2 0.02 57.93 LIMB TRAUMATIC AMPUTATION | 1 0.01 57.94 LIP DRY | 1 0.01 57.95 LIPASE INCREASED | 1 0.01 57.96 LIPODYSTROPHY ACQUIRED | 1 0.01 57.97 LIPOHYPERTROPHY | 1 0.01 57.98 LISTERIA SEPSIS | 1 0.01 57.99 LISTERIOSIS | 1 0.01 58.00 LISTLESS | 1 0.01 58.01 LIVER DISORDER | 20 0.20 58.21 LIVER FUNCTION TEST ABNORMAL | 14 0.14 58.35 LIVER TRANSPLANT | 1 0.01 58.36 LOBAR PNEUMONIA | 2 0.02 58.38 LOCAL SWELLING | 3 0.03 58.41 LOCALISED INFECTION | 2 0.02 58.43 LOCALISED OEDEMA | 1 0.01 58.44 LOGORRHOEA | 2 0.02 58.46 LOSS OF CONSCIOUSNESS | 37 0.37 58.83 LOSS OF CONTROL OF LEGS | 2 0.02 58.85 LOW DENSITY LIPOPROTEIN INCREASED | 2 0.02 58.87 LOWER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 58.88 LOWER LIMB FRACTURE | 3 0.03 58.91 LOWER RESPIRATORY TRACT INFECTION | 3 0.03 58.94 LUMBAR RADICULOPATHY | 1 0.01 58.95 LUMBAR SPINAL STENOSIS | 1 0.01 58.96 LUMBAR VERTEBRAL FRACTURE | 1 0.01 58.97 LUNG ABSCESS | 2 0.02 58.99 LUNG CANCER METASTATIC | 1 0.01 59.00 LUNG DISORDER | 4 0.04 59.04 LUNG INFECTION | 1 0.01 59.05 LUNG INFILTRATION | 3 0.03 59.08 LUNG INJURY | 1 0.01 59.09 LUNG NEOPLASM | 4 0.04 59.13 LUNG NEOPLASM MALIGNANT | 2 0.02 59.15 LUPUS NEPHRITIS | 1 0.01 59.16 LUPUS-LIKE SYNDROME | 3 0.03 59.19 LYMPHADENITIS | 1 0.01 59.20 LYMPHADENOPATHY | 7 0.07 59.27 LYMPHOCYTE COUNT ABNORMAL | 1 0.01 59.28 LYMPHOCYTE COUNT INCREASED | 2 0.02 59.30 LYMPHOCYTE STIMULATION TEST POSITIVE | 1 0.01 59.31 LYMPHOEDEMA | 1 0.01 59.32 LYMPHOMA | 5 0.05 59.37 LYMPHOPENIA | 4 0.04 59.41 LYMPHOPROLIFERATIVE DISORDER | 1 0.01 59.42 MACROCYTOSIS | 1 0.01 59.43 MACULAR OEDEMA | 4 0.04 59.47 MAJOR DEPRESSION | 1 0.01 59.48 MALABSORPTION | 2 0.02 59.50 MALAISE | 25 0.25 59.75 MALARIA | 1 0.01 59.76 MALE PATTERN BALDNESS | 1 0.01 59.77 MALIGNANT HYPERTENSION | 3 0.03 59.80 MALIGNANT MELANOMA | 5 0.05 59.85 MALIGNANT NEOPLASM PROGRESSION | 6 0.06 59.91 MALNUTRITION | 2 0.02 59.93 MANIA | 8 0.08 60.01 MARITAL PROBLEM | 1 0.01 60.02 MASKED FACIES | 1 0.01 60.03 MASS | 1 0.01 60.04 MEAN CELL VOLUME INCREASED | 1 0.01 60.05 MEDIASTINAL DISORDER | 1 0.01 60.06 MEDICAL DEVICE CHANGE | 4 0.04 60.10 MEDICAL DEVICE COMPLICATION | 2 0.02 60.12 MEDICAL DEVICE DISCOMFORT | 20 0.20 60.32 MEDICATION ERROR | 41 0.41 60.73 MELAENA | 5 0.05 60.78 MEMORY IMPAIRMENT | 10 0.10 60.88 MENIERE'S DISEASE | 1 0.01 60.89 MENINGITIS | 1 0.01 60.90 MENINGITIS BACTERIAL | 1 0.01 60.91 MENINGITIS LISTERIA | 1 0.01 60.92 MENINGOMYELOCELE | 1 0.01 60.93 MENISCUS LESION | 1 0.01 60.94 MENOMETRORRHAGIA | 1 0.01 60.95 MENOPAUSAL SYMPTOMS | 1 0.01 60.96 MENORRHAGIA | 19 0.19 61.15 MENSTRUAL DISORDER | 8 0.08 61.23 MENSTRUATION IRREGULAR | 6 0.06 61.29 MENTAL DISORDER | 4 0.04 61.33 MENTAL IMPAIRMENT | 5 0.05 61.38 MENTAL STATUS CHANGES | 7 0.07 61.45 METABOLIC ACIDOSIS | 8 0.08 61.53 METABOLIC ALKALOSIS | 1 0.01 61.54 METABOLIC DISORDER | 1 0.01 61.55 METABOLIC ENCEPHALOPATHY | 2 0.02 61.57 METAL POISONING | 64 0.64 62.21 METASTASES TO BONE | 2 0.02 62.23 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 62.24 METASTASES TO LIVER | 5 0.05 62.29 METASTASES TO LUNG | 5 0.05 62.34 METASTASES TO LYMPH NODES | 1 0.01 62.35 METASTASES TO MENINGES | 1 0.01 62.36 METASTASES TO OVARY | 1 0.01 62.37 METASTASES TO SPINE | 1 0.01 62.38 METASTATIC NEOPLASM | 1 0.01 62.39 METRORRHAGIA | 185 1.85 64.24 MICTURITION DISORDER | 1 0.01 64.25 MICTURITION URGENCY | 2 0.02 64.27 MIGRAINE | 16 0.16 64.43 MIGRAINE WITHOUT AURA | 1 0.01 64.44 MIOSIS | 5 0.05 64.49 MITRAL VALVE CALCIFICATION | 1 0.01 64.50 MITRAL VALVE INCOMPETENCE | 9 0.09 64.59 MITRAL VALVE PROLAPSE | 1 0.01 64.60 MOBILITY DECREASED | 1 0.01 64.61 MONARTHRITIS | 2 0.02 64.63 MOOD ALTERED | 5 0.05 64.68 MOOD SWINGS | 8 0.08 64.76 MOTION SICKNESS | 1 0.01 64.77 MOTOR DYSFUNCTION | 5 0.05 64.82 MOUTH BREATHING | 1 0.01 64.83 MOUTH HAEMORRHAGE | 2 0.02 64.85 MOUTH INJURY | 1 0.01 64.86 MOUTH ULCERATION | 3 0.03 64.89 MOVEMENT DISORDER | 5 0.05 64.94 MUCOSAL EROSION | 1 0.01 64.95 MUCOSAL INFLAMMATION | 1 0.01 64.96 MULTI-ORGAN DISORDER | 1 0.01 64.97 MULTI-ORGAN FAILURE | 18 0.18 65.15 MULTIPLE CONGENITAL ABNORMALITIES | 1 0.01 65.16 MULTIPLE DRUG OVERDOSE | 9 0.09 65.25 MULTIPLE FRACTURES | 1 0.01 65.26 MULTIPLE MYELOMA | 1 0.01 65.27 MULTIPLE SCLEROSIS | 6 0.06 65.33 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 65.34 MULTIPLE-DRUG RESISTANCE | 1 0.01 65.35 MURDER | 1 0.01 65.36 MUSCLE ATROPHY | 1 0.01 65.37 MUSCLE CONTRACTIONS INVOLUNTARY | 1 0.01 65.38 MUSCLE ENZYME INCREASED | 1 0.01 65.39 MUSCLE HAEMORRHAGE | 3 0.03 65.42 MUSCLE RIGIDITY | 3 0.03 65.45 MUSCLE SPASMS | 38 0.38 65.83 MUSCLE SPASTICITY | 1 0.01 65.84 MUSCLE TIGHTNESS | 2 0.02 65.86 MUSCLE TWITCHING | 5 0.05 65.91 MUSCULAR WEAKNESS | 10 0.10 66.01 MUSCULOSKELETAL CHEST PAIN | 1 0.01 66.02 MUSCULOSKELETAL DISCOMFORT | 1 0.01 66.03 MUSCULOSKELETAL PAIN | 2 0.02 66.05 MUSCULOSKELETAL STIFFNESS | 7 0.07 66.12 MUTISM | 2 0.02 66.14 MYALGIA | 29 0.29 66.43 MYASTHENIA GRAVIS | 3 0.03 66.46 MYASTHENIC SYNDROME | 1 0.01 66.47 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 66.48 MYDRIASIS | 4 0.04 66.52 MYELODYSPLASTIC SYNDROME | 3 0.03 66.55 MYELOID LEUKAEMIA | 1 0.01 66.56 MYOCARDIAL INFARCTION | 74 0.74 67.30 MYOCARDIAL ISCHAEMIA | 7 0.07 67.37 MYOCARDITIS | 1 0.01 67.38 MYOCLONUS | 4 0.04 67.42 MYOFASCIAL SPASM | 1 0.01 67.43 MYOGLOBIN BLOOD INCREASED | 1 0.01 67.44 MYOGLOBINAEMIA | 1 0.01 67.45 MYOGLOBINURIA | 2 0.02 67.47 MYOPATHY STEROID | 1 0.01 67.48 MYOPIA | 1 0.01 67.49 MYOSITIS | 7 0.07 67.56 NAIL DISORDER | 1 0.01 67.57 NARCOTIC INTOXICATION | 1 0.01 67.58 NASAL CONGESTION | 7 0.07 67.65 NASAL DISCOMFORT | 2 0.02 67.67 NASAL DISORDER | 1 0.01 67.68 NASAL DRYNESS | 1 0.01 67.69 NASOPHARYNGITIS | 8 0.08 67.77 NAUSEA | 187 1.87 69.64 NECK INJURY | 3 0.03 69.67 NECK PAIN | 9 0.09 69.76 NECROSIS | 2 0.02 69.78 NECROTISING SCLERITIS | 1 0.01 69.79 NEGATIVISM | 1 0.01 69.80 NEONATAL APNOEIC ATTACK | 3 0.03 69.83 NEONATAL DISORDER | 7 0.07 69.90 NEONATAL RESPIRATORY DISTRESS SYNDROME | 1 0.01 69.91 NEONATAL TACHYPNOEA | 1 0.01 69.92 NEOPLASM | 1 0.01 69.93 NEOPLASM MALIGNANT | 1 0.01 69.94 NEOPLASM PROGRESSION | 2 0.02 69.96 NEOPLASM RECURRENCE | 2 0.02 69.98 NEPHRITIS INTERSTITIAL | 4 0.04 70.02 NEPHROLITHIASIS | 6 0.06 70.08 NEPHROSCLEROSIS | 1 0.01 70.09 NEPHROTIC SYNDROME | 3 0.03 70.12 NERVE COMPRESSION | 1 0.01 70.13 NERVE CONDUCTION STUDIES ABNORMAL | 1 0.01 70.14 NERVE INJURY | 2 0.02 70.16 NERVOUS SYSTEM DISORDER | 72 0.72 70.88 NERVOUSNESS | 11 0.11 70.99 NEUROENDOCRINE CARCINOMA | 1 0.01 71.00 NEUROGENIC BLADDER | 1 0.01 71.01 NEUROLEPTIC MALIGNANT SYNDROME | 2 0.02 71.03 NEUROLOGICAL SYMPTOM | 3 0.03 71.06 NEUROPATHY | 4 0.04 71.10 NEUROPATHY PERIPHERAL | 7 0.07 71.17 NEUROTOXICITY | 4 0.04 71.21 NEUTROPENIA | 13 0.13 71.34 NEUTROPENIC INFECTION | 1 0.01 71.35 NEUTROPENIC SEPSIS | 2 0.02 71.37 NEUTROPHIL COUNT ABNORMAL | 3 0.03 71.40 NEUTROPHIL COUNT DECREASED | 3 0.03 71.43 NEUTROPHIL COUNT INCREASED | 1 0.01 71.44 NEUTROPHIL PERCENTAGE DECREASED | 2 0.02 71.46 NEUTROPHILIA | 2 0.02 71.48 NICOTINE DEPENDENCE | 1 0.01 71.49 NIGHT CRAMPS | 1 0.01 71.50 NIGHT SWEATS | 5 0.05 71.55 NIGHTMARE | 8 0.08 71.63 NIPPLE PAIN | 1 0.01 71.64 NITRITE URINE PRESENT | 1 0.01 71.65 NO ADVERSE DRUG EFFECT | 2 0.02 71.67 NOCTURIA | 2 0.02 71.69 NODAL ARRHYTHMIA | 2 0.02 71.71 NODAL RHYTHM | 1 0.01 71.72 NODULE | 1 0.01 71.73 NON-CARDIAC CHEST PAIN | 3 0.03 71.76 NON-HODGKIN'S LYMPHOMA | 6 0.06 71.82 NON-SMALL CELL LUNG CANCER | 1 0.01 71.83 NORMAL PRESSURE HYDROCEPHALUS | 1 0.01 71.84 NORMOCHROMIC NORMOCYTIC ANAEMIA | 3 0.03 71.87 NOSOCOMIAL INFECTION | 1 0.01 71.88 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 71.89 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 3 0.03 71.92 NYSTAGMUS | 1 0.01 71.93 OBLITERATIVE BRONCHIOLITIS | 1 0.01 71.94 OBSESSIVE THOUGHTS | 1 0.01 71.95 OBSTRUCTION | 1 0.01 71.96 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 71.97 OBSTRUCTIVE UROPATHY | 1 0.01 71.98 OCULAR HYPERAEMIA | 3 0.03 72.01 OCULAR ICTERUS | 2 0.02 72.03 OCULAR VASCULAR DISORDER | 1 0.01 72.04 OEDEMA | 10 0.10 72.14 OEDEMA GENITAL | 1 0.01 72.15 OEDEMA MOUTH | 1 0.01 72.16 OEDEMA PERIPHERAL | 41 0.41 72.57 OESOPHAGEAL CARCINOMA | 1 0.01 72.58 OESOPHAGEAL SPASM | 1 0.01 72.59 OESOPHAGEAL ULCER | 1 0.01 72.60 OESOPHAGEAL VARICES HAEMORRHAGE | 1 0.01 72.61 OESOPHAGITIS | 4 0.04 72.65 OESOPHAGITIS ULCERATIVE | 1 0.01 72.66 OESTRADIOL DECREASED | 1 0.01 72.67 OFF LABEL USE | 2 0.02 72.69 OLIGOHYDRAMNIOS | 1 0.01 72.70 OLIGOMENORRHOEA | 25 0.25 72.95 OLIGURIA | 3 0.03 72.98 ONCOCYTOMA | 1 0.01 72.99 OPEN ANGLE GLAUCOMA | 1 0.01 73.00 OPIATES POSITIVE | 1 0.01 73.01 OPISTHOTONUS | 1 0.01 73.02 OPTIC ISCHAEMIC NEUROPATHY | 2 0.02 73.04 OPTIC NEURITIS RETROBULBAR | 1 0.01 73.05 ORAL CANDIDIASIS | 2 0.02 73.07 ORAL DISCOMFORT | 2 0.02 73.09 ORAL INFECTION | 1 0.01 73.10 ORAL INTAKE REDUCED | 6 0.06 73.16 ORAL PRURITUS | 2 0.02 73.18 ORAL SOFT TISSUE DISORDER | 1 0.01 73.19 ORGASM ABNORMAL | 2 0.02 73.21 OROPHARYNGEAL SWELLING | 5 0.05 73.26 ORTHOPNOEA | 1 0.01 73.27 ORTHOSTATIC HYPOTENSION | 5 0.05 73.32 OSCILLOPSIA | 1 0.01 73.33 OSTEITIS | 1 0.01 73.34 OSTEOARTHRITIS | 5 0.05 73.39 OSTEOCHONDROSIS | 1 0.01 73.40 OSTEOMALACIA | 1 0.01 73.41 OSTEOMYELITIS | 2 0.02 73.43 OSTEOMYELITIS ACUTE | 1 0.01 73.44 OSTEOPOROSIS | 2 0.02 73.46 OTITIS MEDIA | 1 0.01 73.47 OTORRHOEA | 1 0.01 73.48 OVARIAN CANCER | 19 0.19 73.67 OVARIAN CYST | 3 0.03 73.70 OVARIAN DISORDER | 1 0.01 73.71 OVARIAN NEOPLASM | 1 0.01 73.72 OVERDOSE | 24 0.24 73.96 OXYGEN SATURATION DECREASED | 10 0.10 74.06 PAIN | 38 0.38 74.44 PAIN IN EXTREMITY | 57 0.57 75.01 PAIN IN JAW | 1 0.01 75.02 PALLOR | 3 0.03 75.05 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 2 0.02 75.07 PALPITATIONS | 31 0.31 75.38 PANCREAS LIPOMATOSIS | 1 0.01 75.39 PANCREATIC DUCT OBSTRUCTION | 1 0.01 75.40 PANCREATIC NEOPLASM | 1 0.01 75.41 PANCREATIC PSEUDOCYST | 1 0.01 75.42 PANCREATITIS | 14 0.14 75.56 PANCREATITIS ACUTE | 4 0.04 75.60 PANCREATITIS NECROTISING | 1 0.01 75.61 PANCYTOPENIA | 18 0.18 75.79 PANIC ATTACK | 8 0.08 75.87 PANIC DISORDER | 4 0.04 75.91 PANIC REACTION | 1 0.01 75.92 PANNICULITIS | 1 0.01 75.93 PAPILLOEDEMA | 1 0.01 75.94 PARAESTHESIA | 29 0.29 76.23 PARAESTHESIA ORAL | 3 0.03 76.26 PARALYSIS | 2 0.02 76.28 PARALYSIS FLACCID | 2 0.02 76.30 PARANOIA | 5 0.05 76.35 PARAPLEGIA | 2 0.02 76.37 PARAPSORIASIS | 1 0.01 76.38 PARESIS | 2 0.02 76.40 PARKINSON'S DISEASE | 2 0.02 76.42 PARKINSONISM | 1 0.01 76.43 PAROSMIA | 1 0.01 76.44 PAROTITIS | 2 0.02 76.46 PARTIAL SEIZURES | 1 0.01 76.47 PATHOGEN RESISTANCE | 3 0.03 76.50 PCO2 DECREASED | 1 0.01 76.51 PELVIC PAIN | 2 0.02 76.53 PENILE BLISTER | 1 0.01 76.54 PENILE HAEMORRHAGE | 1 0.01 76.55 PENILE PAIN | 2 0.02 76.57 PENIS DISORDER | 2 0.02 76.59 PEPTIC ULCER | 1 0.01 76.60 PEPTIC ULCER PERFORATION | 1 0.01 76.61 PERFORMANCE STATUS DECREASED | 1 0.01 76.62 PERICARDIAL EFFUSION | 1 0.01 76.63 PERICARDIAL EXCISION | 1 0.01 76.64 PERICARDIAL HAEMORRHAGE | 1 0.01 76.65 PERICARDIAL RUB | 1 0.01 76.66 PERICARDITIS | 2 0.02 76.68 PERICARDITIS CONSTRICTIVE | 1 0.01 76.69 PERIORBITAL OEDEMA | 2 0.02 76.71 PERIPHERAL ARTERY ANGIOPLASTY | 1 0.01 76.72 PERIPHERAL COLDNESS | 1 0.01 76.73 PERIPHERAL OCCLUSIVE DISEASE | 1 0.01 76.74 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 76.75 PERIPHERAL VASCULAR DISORDER | 2 0.02 76.77 PERITONEAL DIALYSIS | 1 0.01 76.78 PERITONEAL HAEMORRHAGE | 2 0.02 76.80 PERITONITIS | 2 0.02 76.82 PERNICIOUS ANAEMIA | 1 0.01 76.83 PERONEAL NERVE INJURY | 1 0.01 76.84 PERSONALITY CHANGE | 3 0.03 76.87 PERSONALITY DISORDER | 2 0.02 76.89 PERTUSSIS | 1 0.01 76.90 PETECHIAE | 5 0.05 76.95 PETIT MAL EPILEPSY | 1 0.01 76.96 PHARMACEUTICAL PRODUCT COMPLAINT | 18 0.18 77.14 PHARYNGEAL ERYTHEMA | 2 0.02 77.16 PHARYNGEAL HAEMORRHAGE | 1 0.01 77.17 PHARYNGEAL ULCERATION | 1 0.01 77.18 PHARYNGITIS | 4 0.04 77.22 PHARYNGOLARYNGEAL PAIN | 7 0.07 77.29 PHLEBITIS | 1 0.01 77.30 PHLEBITIS SUPERFICIAL | 1 0.01 77.31 PHLEBOTHROMBOSIS | 1 0.01 77.32 PHOBIA | 1 0.01 77.33 PHOTOPHOBIA | 2 0.02 77.35 PHOTOSENSITIVITY REACTION | 5 0.05 77.40 PIGMENTARY GLAUCOMA | 1 0.01 77.41 PIGMENTATION DISORDER | 1 0.01 77.42 PIGMENTED NAEVUS | 1 0.01 77.43 PILONIDAL CYST CONGENITAL | 1 0.01 77.44 PITTING OEDEMA | 1 0.01 77.45 PITUITARY ENLARGEMENT | 1 0.01 77.46 PITYRIASIS ROSEA | 1 0.01 77.47 PLACENTAL DISORDER | 1 0.01 77.48 PLASMINOGEN DECREASED | 1 0.01 77.49 PLATELET AGGREGATION | 1 0.01 77.50 PLATELET COUNT DECREASED | 11 0.11 77.61 PLATELET COUNT INCREASED | 3 0.03 77.64 PLEURAL EFFUSION | 17 0.17 77.81 PLEURAL FIBROSIS | 1 0.01 77.82 PLEURISY | 3 0.03 77.85 PLEURITIC PAIN | 1 0.01 77.86 PNEUMOCYSTIS JIROVECI PNEUMONIA | 8 0.08 77.94 PNEUMOMEDIASTINUM | 1 0.01 77.95 PNEUMONIA | 30 0.30 78.25 PNEUMONIA BACTERIAL | 1 0.01 78.26 PNEUMONIA CHLAMYDIAL | 1 0.01 78.27 PNEUMONIA LEGIONELLA | 2 0.02 78.29 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 78.30 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 78.31 PNEUMONIA VIRAL | 1 0.01 78.32 PNEUMONITIS | 8 0.08 78.40 PNEUMONITIS CRYPTOCOCCAL | 1 0.01 78.41 PNEUMOTHORAX | 1 0.01 78.42 PO2 ABNORMAL | 1 0.01 78.43 PO2 DECREASED | 3 0.03 78.46 POISONING | 2 0.02 78.48 POLLAKIURIA | 9 0.09 78.57 POLYCYSTIC OVARIES | 1 0.01 78.58 POLYMENORRHOEA | 1 0.01 78.59 POLYMYOSITIS | 1 0.01 78.60 POLYNEUROPATHY | 3 0.03 78.63 POLYP | 1 0.01 78.64 POLYP COLORECTAL | 1 0.01 78.65 POLYTRAUMATISM | 4 0.04 78.69 POLYURIA | 4 0.04 78.73 POOR PERIPHERAL CIRCULATION | 2 0.02 78.75 PORTAL HYPERTENSION | 1 0.01 78.76 POST COITAL BLEEDING | 4 0.04 78.80 POST PROCEDURAL CELLULITIS | 1 0.01 78.81 POST PROCEDURAL COMPLICATION | 10 0.10 78.91 POST PROCEDURAL HAEMORRHAGE | 1 0.01 78.92 POST PROCEDURAL PAIN | 2 0.02 78.94 POST-TRAUMATIC OSTEOPOROSIS | 1 0.01 78.95 POST-TRAUMATIC STRESS DISORDER | 3 0.03 78.98 POSTMENOPAUSAL HAEMORRHAGE | 1 0.01 78.99 POSTNASAL DRIP | 1 0.01 79.00 POSTOPERATIVE FEVER | 1 0.01 79.01 POSTOPERATIVE INFECTION | 1 0.01 79.02 PRE-ECLAMPSIA | 1 0.01 79.03 PRECANCEROUS SKIN LESION | 1 0.01 79.04 PREGNANCY | 4 0.04 79.08 PREGNANCY ON ORAL CONTRACEPTIVE | 6 0.06 79.14 PREMATURE BABY | 6 0.06 79.20 PREMATURE LABOUR | 2 0.02 79.22 PREMATURE RUPTURE OF MEMBRANES | 1 0.01 79.23 PREMENSTRUAL SYNDROME | 3 0.03 79.26 PRESCRIBED OVERDOSE | 3 0.03 79.29 PRIAPISM | 2 0.02 79.31 PROCEDURAL COMPLICATION | 4 0.04 79.35 PRODUCTIVE COUGH | 3 0.03 79.38 PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 79.39 PROSTATE CANCER | 1 0.01 79.40 PROSTATE CANCER METASTATIC | 1 0.01 79.41 PROSTATE INFECTION | 1 0.01 79.42 PROSTATIC DISORDER | 1 0.01 79.43 PROSTATIC OPERATION | 1 0.01 79.44 PROSTATIC PAIN | 1 0.01 79.45 PROSTATIC SPECIFIC ANTIGEN INCREASED | 2 0.02 79.47 PROTEIN TOTAL DECREASED | 2 0.02 79.49 PROTEIN TOTAL INCREASED | 1 0.01 79.50 PROTEIN URINE PRESENT | 1 0.01 79.51 PROTEINURIA | 5 0.05 79.56 PROTEUS INFECTION | 2 0.02 79.58 PROTHROMBIN TIME PROLONGED | 5 0.05 79.63 PROTHROMBIN TIME RATIO INCREASED | 1 0.01 79.64 PROTHROMBIN TIME SHORTENED | 2 0.02 79.66 PRURIGO | 1 0.01 79.67 PRURITUS | 33 0.33 80.00 PRURITUS ANI | 1 0.01 80.01 PRURITUS GENERALISED | 8 0.08 80.09 PRURITUS GENITAL | 1 0.01 80.10 PSEUDOCYST | 1 0.01 80.11 PSEUDOMENINGOCELE | 1 0.01 80.12 PSEUDOMONAS INFECTION | 2 0.02 80.14 PSORIASIS | 5 0.05 80.19 PSORIATIC ARTHROPATHY | 1 0.01 80.20 PSYCHIATRIC SYMPTOM | 1 0.01 80.21 PSYCHOMOTOR AGITATION | 1 0.01 80.22 PSYCHOMOTOR HYPERACTIVITY | 2 0.02 80.24 PSYCHOSOMATIC DISEASE | 1 0.01 80.25 PSYCHOTIC DISORDER | 4 0.04 80.29 PULMONARY ALVEOLAR HAEMORRHAGE | 2 0.02 80.31 PULMONARY ARTERY ANEURYSM | 1 0.01 80.32 PULMONARY ARTERY THROMBOSIS | 1 0.01 80.33 PULMONARY CAVITATION | 1 0.01 80.34 PULMONARY CONGESTION | 4 0.04 80.38 PULMONARY EMBOLISM | 26 0.26 80.64 PULMONARY FIBROSIS | 3 0.03 80.67 PULMONARY FUNCTION TEST ABNORMAL | 1 0.01 80.68 PULMONARY GRANULOMA | 1 0.01 80.69 PULMONARY HILUM MASS | 1 0.01 80.70 PULMONARY HYPERTENSION | 12 0.12 80.82 PULMONARY INFARCTION | 2 0.02 80.84 PULMONARY MYCOSIS | 1 0.01 80.85 PULMONARY OEDEMA | 4 0.04 80.89 PULMONARY TOXICITY | 2 0.02 80.91 PULMONARY TUBERCULOSIS | 4 0.04 80.95 PULMONARY VASCULAR DISORDER | 4 0.04 80.99 PULMONARY VASCULITIS | 1 0.01 81.00 PULSE ABSENT | 1 0.01 81.01 PULSE PRESSURE DECREASED | 1 0.01 81.02 PUPIL FIXED | 1 0.01 81.03 PUPILLARY DISORDER | 1 0.01 81.04 PUPILLARY REFLEX IMPAIRED | 2 0.02 81.06 PURULENT DISCHARGE | 1 0.01 81.07 PYELECTASIA | 1 0.01 81.08 PYELONEPHRITIS | 4 0.04 81.12 PYLORIC STENOSIS | 1 0.01 81.13 PYOMETRA | 1 0.01 81.14 PYREXIA | 70 0.70 81.84 PYURIA | 1 0.01 81.85 QUADRIPARESIS | 1 0.01 81.86 RADIATION INJURY | 1 0.01 81.87 RADICULAR PAIN | 1 0.01 81.88 RADICULOPATHY | 3 0.03 81.91 RALES | 2 0.02 81.93 RASH | 57 0.57 82.50 RASH ERYTHEMATOUS | 7 0.07 82.57 RASH GENERALISED | 7 0.07 82.64 RASH MACULAR | 2 0.02 82.66 RASH MACULO-PAPULAR | 4 0.04 82.70 RASH NEONATAL | 1 0.01 82.71 RASH PAPULAR | 2 0.02 82.73 RASH PRURITIC | 10 0.10 82.83 RASH PUSTULAR | 1 0.01 82.84 RASH VESICULAR | 2 0.02 82.86 RAYNAUD'S PHENOMENON | 2 0.02 82.88 REACTION TO MEDICAL AGENT PRESERVATIVES | 1 0.01 82.89 READING DISORDER | 1 0.01 82.90 RECTAL ADENOMA | 1 0.01 82.91 RECTAL HAEMORRHAGE | 13 0.13 83.04 RECTAL NEOPLASM | 1 0.01 83.05 RECTAL TENESMUS | 1 0.01 83.06 RED BLOOD CELL COUNT DECREASED | 8 0.08 83.14 RED BLOOD CELL COUNT INCREASED | 2 0.02 83.16 RED BLOOD CELL SEDIMENTATION RATE INC.. | 2 0.02 83.18 RED CELL DISTRIBUTION WIDTH ABNORMAL | 1 0.01 83.19 RED MAN SYNDROME | 4 0.04 83.23 REFUSAL OF TREATMENT BY PATIENT | 4 0.04 83.27 RENAL AGENESIS | 1 0.01 83.28 RENAL ARTERY STENOSIS | 1 0.01 83.29 RENAL CYST | 1 0.01 83.30 RENAL DISORDER | 7 0.07 83.37 RENAL DYSPLASIA | 1 0.01 83.38 RENAL FAILURE | 29 0.29 83.67 RENAL FAILURE ACUTE | 36 0.36 84.03 RENAL FUNCTION TEST ABNORMAL | 1 0.01 84.04 RENAL IMPAIRMENT | 22 0.22 84.26 RENAL PAIN | 1 0.01 84.27 RENAL TUBULAR DISORDER | 2 0.02 84.29 RENAL TUBULAR NECROSIS | 4 0.04 84.33 RENAL VEIN OCCLUSION | 1 0.01 84.34 RESPIRATION ABNORMAL | 2 0.02 84.36 RESPIRATORY ACIDOSIS | 2 0.02 84.38 RESPIRATORY ARREST | 10 0.10 84.48 RESPIRATORY DEPRESSION | 4 0.04 84.52 RESPIRATORY DISORDER | 6 0.06 84.58 RESPIRATORY DISTRESS | 5 0.05 84.63 RESPIRATORY FAILURE | 15 0.15 84.78 RESPIRATORY RATE DECREASED | 3 0.03 84.81 RESPIRATORY RATE INCREASED | 2 0.02 84.83 RESPIRATORY TRACT CONGESTION | 2 0.02 84.85 RESPIRATORY TRACT HAEMORRHAGE | 1 0.01 84.86 RESPIRATORY TRACT INFECTION | 4 0.04 84.90 RESTLESS LEGS SYNDROME | 2 0.02 84.92 RESTLESSNESS | 4 0.04 84.96 RETCHING | 1 0.01 84.97 RETINAL DETACHMENT | 1 0.01 84.98 RETINAL HAEMORRHAGE | 1 0.01 84.99 RETINAL OEDEMA | 1 0.01 85.00 RETINAL VEIN OCCLUSION | 3 0.03 85.03 RETINOPATHY HYPERTENSIVE | 1 0.01 85.04 RETINOPATHY PROLIFERATIVE | 1 0.01 85.05 RETROPERITONEAL HAEMATOMA | 1 0.01 85.06 RHABDOMYOLYSIS | 12 0.12 85.18 RHEUMATOID ARTHRITIS | 10 0.10 85.28 RHINITIS ALLERGIC | 4 0.04 85.32 RHINITIS SEASONAL | 1 0.01 85.33 RHINORRHOEA | 2 0.02 85.35 RIB FRACTURE | 2 0.02 85.37 RIGHT VENTRICULAR FAILURE | 4 0.04 85.41 ROAD TRAFFIC ACCIDENT | 6 0.06 85.47 ROSACEA | 2 0.02 85.49 ROTATOR CUFF SYNDROME | 3 0.03 85.52 SALIVARY DUCT OBSTRUCTION | 1 0.01 85.53 SALIVARY GLAND CALCULUS | 1 0.01 85.54 SALIVARY HYPERSECRETION | 3 0.03 85.57 SCHIZOPHRENIA | 2 0.02 85.59 SCIATICA | 2 0.02 85.61 SCLERODERMA | 1 0.01 85.62 SCOLIOSIS | 2 0.02 85.64 SCREAMING | 1 0.01 85.65 SCROTAL ULCER | 1 0.01 85.66 SEBORRHOEA | 1 0.01 85.67 SEDATION | 3 0.03 85.70 SELF ESTEEM DECREASED | 1 0.01 85.71 SELF INJURIOUS BEHAVIOUR | 1 0.01 85.72 SELF-INJURIOUS IDEATION | 1 0.01 85.73 SELF-MEDICATION | 1 0.01 85.74 SENSATION OF FOREIGN BODY | 1 0.01 85.75 SENSATION OF HEAVINESS | 2 0.02 85.77 SENSATION OF PRESSURE | 2 0.02 85.79 SENSORY DISTURBANCE | 4 0.04 85.83 SENSORY LOSS | 4 0.04 85.87 SEPSIS | 16 0.16 86.03 SEPSIS NEONATAL | 1 0.01 86.04 SEPTIC SHOCK | 9 0.09 86.13 SERONEGATIVE ARTHRITIS | 1 0.01 86.14 SEROTONIN SYNDROME | 10 0.10 86.24 SERUM SEROTONIN DECREASED | 2 0.02 86.26 SERUM SICKNESS | 6 0.06 86.32 SEXUAL DYSFUNCTION | 3 0.03 86.35 SHIFT TO THE LEFT | 1 0.01 86.36 SHOCK | 7 0.07 86.43 SHOULDER OPERATION | 1 0.01 86.44 SHUNT INFECTION | 1 0.01 86.45 SHUNT OCCLUSION | 3 0.03 86.48 SICCA SYNDROME | 1 0.01 86.49 SICK SINUS SYNDROME | 2 0.02 86.51 SILENT MYOCARDIAL INFARCTION | 1 0.01 86.52 SIMPLE PARTIAL SEIZURES | 2 0.02 86.54 SINUS ARREST | 1 0.01 86.55 SINUS BRADYCARDIA | 8 0.08 86.63 SINUS CONGESTION | 1 0.01 86.64 SINUS DISORDER | 1 0.01 86.65 SINUS HEADACHE | 2 0.02 86.67 SINUS TACHYCARDIA | 8 0.08 86.75 SINUSITIS | 13 0.13 86.88 SJOGREN'S SYNDROME | 1 0.01 86.89 SKIN BURNING SENSATION | 4 0.04 86.93 SKIN CANCER | 1 0.01 86.94 SKIN DEPIGMENTATION | 1 0.01 86.95 SKIN DISCOLOURATION | 10 0.10 87.05 SKIN DISORDER | 2 0.02 87.07 SKIN EXFOLIATION | 5 0.05 87.12 SKIN HYPERPIGMENTATION | 5 0.05 87.17 SKIN HYPOPIGMENTATION | 1 0.01 87.18 SKIN INFECTION | 1 0.01 87.19 SKIN IRRITATION | 2 0.02 87.21 SKIN LACERATION | 1 0.01 87.22 SKIN LESION | 4 0.04 87.26 SKIN ODOUR ABNORMAL | 1 0.01 87.27 SKIN REACTION | 2 0.02 87.29 SKIN STRIAE | 2 0.02 87.31 SKIN TEST POSITIVE | 1 0.01 87.32 SKIN ULCER | 1 0.01 87.33 SKIN WARM | 1 0.01 87.34 SKULL FRACTURE | 1 0.01 87.35 SLEEP APNOEA SYNDROME | 6 0.06 87.41 SLEEP DISORDER | 9 0.09 87.50 SLEEP TALKING | 1 0.01 87.51 SLEEP WALKING | 1 0.01 87.52 SLUGGISHNESS | 1 0.01 87.53 SMALL CELL LUNG CANCER METASTATIC | 1 0.01 87.54 SMALL INTESTINAL OBSTRUCTION | 3 0.03 87.57 SMEAR CERVIX ABNORMAL | 1 0.01 87.58 SNEEZING | 1 0.01 87.59 SNORING | 1 0.01 87.60 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 87.61 SOMATOFORM DISORDER | 1 0.01 87.62 SOMNOLENCE | 41 0.41 88.03 SOMNOLENCE NEONATAL | 1 0.01 88.04 SOPOR | 1 0.01 88.05 SPEECH DISORDER | 16 0.16 88.21 SPINAL COLUMN STENOSIS | 1 0.01 88.22 SPINAL COMPRESSION FRACTURE | 3 0.03 88.25 SPINAL CORD COMPRESSION | 1 0.01 88.26 SPINAL CORD INFARCTION | 2 0.02 88.28 SPINAL DISORDER | 1 0.01 88.29 SPINAL FRACTURE | 1 0.01 88.30 SPINAL OSTEOARTHRITIS | 3 0.03 88.33 SPLENIC LESION | 1 0.01 88.34 SPLENIC RUPTURE | 1 0.01 88.35 SPLENOMEGALY | 3 0.03 88.38 SPONDYLOARTHROPATHY | 1 0.01 88.39 SPONDYLOLISTHESIS | 1 0.01 88.40 SPUTUM CULTURE POSITIVE | 4 0.04 88.44 SPUTUM DISCOLOURED | 1 0.01 88.45 SQUAMOUS CELL CARCINOMA OF SKIN | 1 0.01 88.46 SQUAMOUS CELL CARCINOMA OF THE CERVIX | 1 0.01 88.47 STAPHYLOCOCCAL BACTERAEMIA | 2 0.02 88.49 STAPHYLOCOCCAL INFECTION | 14 0.14 88.63 STAPHYLOCOCCAL SEPSIS | 4 0.04 88.67 STARING | 1 0.01 88.68 STATUS EPILEPTICUS | 3 0.03 88.71 STENT PLACEMENT | 1 0.01 88.72 STEREOTYPIC MOVEMENT DISORDER | 2 0.02 88.74 STERNAL FRACTURE | 1 0.01 88.75 STEVENS-JOHNSON SYNDROME | 9 0.09 88.84 STOMACH DISCOMFORT | 9 0.09 88.93 STOMATITIS | 11 0.11 89.04 STOMATITIS HAEMORRHAGIC | 1 0.01 89.05 STOOL ANALYSIS ABNORMAL | 2 0.02 89.07 STREPTOCOCCAL SEPSIS | 1 0.01 89.08 STRESS | 9 0.09 89.17 STRIDOR | 2 0.02 89.19 STUPOR | 4 0.04 89.23 SUBARACHNOID HAEMORRHAGE | 1 0.01 89.24 SUBCUTANEOUS ABSCESS | 1 0.01 89.25 SUBCUTANEOUS EMPHYSEMA | 1 0.01 89.26 SUBDURAL EFFUSION | 1 0.01 89.27 SUBDURAL HAEMATOMA | 1 0.01 89.28 SUBILEUS | 2 0.02 89.30 SUDDEN CARDIAC DEATH | 1 0.01 89.31 SUDDEN DEATH | 7 0.07 89.38 SUICIDAL IDEATION | 25 0.25 89.63 SUICIDE ATTEMPT | 32 0.32 89.95 SUPERINFECTION | 2 0.02 89.97 SUPERINFECTION LUNG | 1 0.01 89.98 SUPPRESSED LACTATION | 1 0.01 89.99 SUPRAVENTRICULAR EXTRASYSTOLES | 3 0.03 90.02 SUPRAVENTRICULAR TACHYCARDIA | 4 0.04 90.06 SURGERY | 3 0.03 90.09 SWELLING | 8 0.08 90.17 SWELLING FACE | 7 0.07 90.24 SWOLLEN TONGUE | 3 0.03 90.27 SYNCOPE | 28 0.28 90.55 SYNCOPE VASOVAGAL | 1 0.01 90.56 SYNDACTYLY | 1 0.01 90.57 SYNOVITIS | 1 0.01 90.58 SYSTEMIC LUPUS ERYTHEMATOSUS | 7 0.07 90.65 SYSTEMIC MYCOSIS | 1 0.01 90.66 TACHYCARDIA | 28 0.28 90.94 TACHYPNOEA | 3 0.03 90.97 TALIPES | 1 0.01 90.98 TEMPERATURE INTOLERANCE | 1 0.01 90.99 TENDERNESS | 2 0.02 91.01 TENDON DISORDER | 4 0.04 91.05 TENDON RUPTURE | 13 0.13 91.18 TENDONITIS | 5 0.05 91.23 TENOSYNOVITIS | 1 0.01 91.24 TENSION | 2 0.02 91.26 TENSION HEADACHE | 1 0.01 91.27 TESTICULAR PAIN | 3 0.03 91.30 TETANY | 1 0.01 91.31 THERAPEUTIC AGENT TOXICITY | 2 0.02 91.33 THERAPEUTIC RESPONSE DECREASED | 12 0.12 91.45 THERAPEUTIC RESPONSE UNEXPECTED | 1 0.01 91.46 THERAPY NON-RESPONDER | 9 0.09 91.55 THERMAL BURN | 1 0.01 91.56 THINKING ABNORMAL | 3 0.03 91.59 THIRST | 3 0.03 91.62 THORACIC VERTEBRAL FRACTURE | 1 0.01 91.63 THORACOTOMY | 2 0.02 91.65 THROAT IRRITATION | 3 0.03 91.68 THROAT TIGHTNESS | 5 0.05 91.73 THROMBOCYTHAEMIA | 1 0.01 91.74 THROMBOCYTOPENIA | 24 0.24 91.98 THROMBOCYTOPENIC PURPURA | 4 0.04 92.02 THROMBOSIS | 16 0.16 92.18 THROMBOTIC STROKE | 1 0.01 92.19 THYROID DISORDER | 1 0.01 92.20 THYROID GLAND CANCER | 1 0.01 92.21 THYROID NEOPLASM | 2 0.02 92.23 THYROXINE DECREASED | 1 0.01 92.24 THYROXINE INCREASED | 1 0.01 92.25 TIBIA FRACTURE | 1 0.01 92.26 TIC | 3 0.03 92.29 TINEL'S SIGN | 1 0.01 92.30 TINNITUS | 11 0.11 92.41 TOE DEFORMITY | 1 0.01 92.42 TONGUE BITING | 1 0.01 92.43 TONGUE BLACK HAIRY | 3 0.03 92.46 TONGUE COATED | 1 0.01 92.47 TONGUE DISORDER | 1 0.01 92.48 TONGUE DRY | 1 0.01 92.49 TONGUE INJURY | 1 0.01 92.50 TONGUE OEDEMA | 1 0.01 92.51 TONGUE ULCERATION | 2 0.02 92.53 TONSILLITIS | 1 0.01 92.54 TOOTH ABSCESS | 2 0.02 92.56 TOOTH INFECTION | 2 0.02 92.58 TOOTHACHE | 1 0.01 92.59 TORSADE DE POINTES | 3 0.03 92.62 TORTICOLLIS | 1 0.01 92.63 TOXIC EPIDERMAL NECROLYSIS | 6 0.06 92.69 TOXIC SHOCK SYNDROME | 1 0.01 92.70 TOXIC SKIN ERUPTION | 3 0.03 92.73 TOXICOLOGIC TEST ABNORMAL | 1 0.01 92.74 TOXOPLASMA SEROLOGY POSITIVE | 1 0.01 92.75 TRACHEAL OEDEMA | 1 0.01 92.76 TRANSAMINASES INCREASED | 3 0.03 92.79 TRANSIENT ISCHAEMIC ATTACK | 13 0.13 92.92 TRANSIENT PSYCHOSIS | 1 0.01 92.93 TRANSPLANT FAILURE | 1 0.01 92.94 TRAUMATIC FRACTURE | 1 0.01 92.95 TREATMENT NONCOMPLIANCE | 20 0.20 93.15 TREATMENT RELATED SECONDARY MALIGNANCY | 3 0.03 93.18 TREMOR | 51 0.51 93.69 TREMOR NEONATAL | 1 0.01 93.70 TRENDELENBURG'S SYMPTOM | 1 0.01 93.71 TRICUSPID VALVE INCOMPETENCE | 9 0.09 93.80 TRIGEMINAL NEURALGIA | 1 0.01 93.81 TRISMUS | 1 0.01 93.82 TRISOMY 18 | 1 0.01 93.83 TROPONIN I INCREASED | 1 0.01 93.84 TROPONIN INCREASED | 1 0.01 93.85 TUBERCULOSIS | 3 0.03 93.88 TUMOUR ULCERATION | 1 0.01 93.89 TWIN PREGNANCY | 1 0.01 93.90 TYPE IV HYPERSENSITIVITY REACTION | 1 0.01 93.91 ULTRASOUND KIDNEY ABNORMAL | 1 0.01 93.92 UNEVALUABLE EVENT | 8 0.08 94.00 UNINTENDED PREGNANCY | 15 0.15 94.15 UNRESPONSIVE TO PAIN STIMULI | 1 0.01 94.16 UPPER GASTROINTESTINAL HAEMORRHAGE | 2 0.02 94.18 UPPER LIMB FRACTURE | 2 0.02 94.20 UPPER RESPIRATORY TRACT INFECTION | 7 0.07 94.27 URAEMIC ENCEPHALOPATHY | 1 0.01 94.28 URETERIC DILATATION | 1 0.01 94.29 URETHRAL SPASM | 1 0.01 94.30 URETHRAL STRICTURE | 1 0.01 94.31 URINARY HESITATION | 2 0.02 94.33 URINARY INCONTINENCE | 4 0.04 94.37 URINARY RETENTION | 5 0.05 94.42 URINARY TRACT INFECTION | 18 0.18 94.60 URINARY TRACT INFECTION FUNGAL | 2 0.02 94.62 URINARY TRACT MALFORMATION | 1 0.01 94.63 URINE FLOW DECREASED | 1 0.01 94.64 URINE HUMAN CHORIONIC GONADOTROPIN IN.. | 1 0.01 94.65 URINE ODOUR ABNORMAL | 1 0.01 94.66 URINE OUTPUT DECREASED | 4 0.04 94.70 URINE OUTPUT INCREASED | 1 0.01 94.71 URINE URIC ACID INCREASED | 1 0.01 94.72 UROGENITAL PROLAPSE | 1 0.01 94.73 UROSEPSIS | 1 0.01 94.74 URTICARIA | 14 0.14 94.88 URTICARIA GENERALISED | 2 0.02 94.90 UTERINE CANCER | 1 0.01 94.91 UTERINE CERVICAL EROSION | 1 0.01 94.92 UTERINE CONTRACTIONS DURING PREGNANCY | 1 0.01 94.93 UTERINE DISORDER | 1 0.01 94.94 UTERINE LEIOMYOMA | 3 0.03 94.97 UTERINE SPASM | 3 0.03 95.00 VAGINAL BURNING SENSATION | 4 0.04 95.04 VAGINAL CANDIDIASIS | 1 0.01 95.05 VAGINAL CONTRACEPTIVE DEVICE EXPELLED | 20 0.20 95.25 VAGINAL DISCHARGE | 19 0.19 95.44 VAGINAL HAEMORRHAGE | 32 0.32 95.76 VAGINAL INFECTION | 10 0.10 95.86 VAGINAL LACERATION | 1 0.01 95.87 VAGINAL MYCOSIS | 32 0.32 96.19 VAGINAL PAIN | 2 0.02 96.21 VAGINAL SWELLING | 1 0.01 96.22 VAGINITIS BACTERIAL | 2 0.02 96.24 VANISHING BILE DUCT SYNDROME | 2 0.02 96.26 VARICOSE VEIN | 1 0.01 96.27 VASCULAR CALCIFICATION | 1 0.01 96.28 VASCULAR MALFORMATION PERIPHERAL | 1 0.01 96.29 VASCULAR OCCLUSION | 2 0.02 96.31 VASCULAR PSEUDOANEURYSM | 1 0.01 96.32 VASCULAR PURPURA | 1 0.01 96.33 VASCULITIS | 3 0.03 96.36 VASCULITIS NECROTISING | 1 0.01 96.37 VASODILATATION | 2 0.02 96.39 VENOUS INSUFFICIENCY | 1 0.01 96.40 VENOUS THROMBOSIS LIMB | 1 0.01 96.41 VENTRICULAR DYSFUNCTION | 3 0.03 96.44 VENTRICULAR EXTRASYSTOLES | 1 0.01 96.45 VENTRICULAR FIBRILLATION | 2 0.02 96.47 VENTRICULAR HYPERTROPHY | 8 0.08 96.55 VENTRICULAR SEPTAL DEFECT | 1 0.01 96.56 VENTRICULAR TACHYCARDIA | 11 0.11 96.67 VERTEBROBASILAR INSUFFICIENCY | 1 0.01 96.68 VERTIGO | 10 0.10 96.78 VESTIBULAR DISORDER | 2 0.02 96.80 VESTIBULAR NEURONITIS | 2 0.02 96.82 VICTIM OF CRIME | 1 0.01 96.83 VICTIM OF HOMICIDE | 1 0.01 96.84 VICTIM OF SPOUSAL ABUSE | 1 0.01 96.85 VIRAL INFECTION | 8 0.08 96.93 VIRAL LOAD INCREASED | 1 0.01 96.94 VIRAL PHARYNGITIS | 1 0.01 96.95 VIRAL UPPER RESPIRATORY TRACT INFECTION | 1 0.01 96.96 VISION BLURRED | 18 0.18 97.14 VISUAL ACUITY REDUCED | 9 0.09 97.23 VISUAL DISTURBANCE | 15 0.15 97.38 VISUAL EVOKED POTENTIALS ABNORMAL | 2 0.02 97.40 VISUAL FIELD DEFECT | 3 0.03 97.43 VISUAL PATHWAY DISORDER | 1 0.01 97.44 VITAMIN B1 DEFICIENCY | 1 0.01 97.45 VITAMIN K DEFICIENCY | 1 0.01 97.46 VITREOUS FLOATERS | 3 0.03 97.49 VITREOUS HAEMORRHAGE | 1 0.01 97.50 VOCAL CORD DISORDER | 1 0.01 97.51 VOCAL CORD PARALYSIS | 1 0.01 97.52 VOMITING | 94 0.94 98.46 VOMITING IN PREGNANCY | 1 0.01 98.47 VOMITING PROJECTILE | 1 0.01 98.48 VULVA CYST | 1 0.01 98.49 VULVOVAGINAL DISCOMFORT | 4 0.04 98.53 VULVOVAGINAL DRYNESS | 5 0.05 98.58 WALKING AID USER | 1 0.01 98.59 WEGENER'S GRANULOMATOSIS | 1 0.01 98.60 WEIGHT DECREASED | 26 0.26 98.86 WEIGHT INCREASED | 39 0.39 99.25 WEIGHT LOSS POOR | 2 0.02 99.27 WEST NILE VIRAL INFECTION | 1 0.01 99.28 WHEELCHAIR USER | 1 0.01 99.29 WHEEZING | 3 0.03 99.32 WHIPLASH INJURY | 1 0.01 99.33 WHITE BLOOD CELL COUNT ABNORMAL | 1 0.01 99.34 WHITE BLOOD CELL COUNT DECREASED | 16 0.16 99.50 WHITE BLOOD CELL COUNT INCREASED | 10 0.10 99.60 WHITE BLOOD CELL DISORDER | 1 0.01 99.61 WITHDRAWAL BLEED | 31 0.31 99.92 WITHDRAWAL BLEEDING IRREGULAR | 2 0.02 99.94 WOUND | 1 0.01 99.95 WOUND COMPLICATION | 1 0.01 99.96 WOUND DEHISCENCE | 1 0.01 99.97 WOUND INFECTION | 1 0.01 99.98 WRIST FRACTURE | 1 0.01 99.99 YAWNING | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015